<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">108845</article-id>
<article-id pub-id-type="doi">10.7554/eLife.108845</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.108845.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.3</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories><title-group>
<article-title>Acute opioid responses are modulated by dynamic interactions of <italic>Oprm1</italic> and <italic>Fgf12</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1774-0385</contrib-id>
<name>
<surname>Lemen</surname>
<given-names>Paige M</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zuo</surname>
<given-names>Yanning</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8002-7267</contrib-id>
<name>
<surname>Hatoum</surname>
<given-names>Alexander S</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3153-0170</contrib-id>
<name>
<surname>Dickson</surname>
<given-names>Price E</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mittleman</surname>
<given-names>Guy</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0313-793X</contrib-id>
<name>
<surname>Agrawal</surname>
<given-names>Arpana</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7796-587X</contrib-id>
<name>
<surname>Reiner</surname>
<given-names>Benjamin C</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4733-2286</contrib-id>
<name>
<surname>Berrettini</surname>
<given-names>Wade</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7397-8910</contrib-id>
<name>
<surname>Ashbrook</surname>
<given-names>David G</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0612-6432</contrib-id>
<name>
<surname>Gunturkun</surname>
<given-names>Mustafa Hakan</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xusheng</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4909-635X</contrib-id>
<name>
<surname>Mulligan</surname>
<given-names>Megan K</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0089-5433</contrib-id>
<name>
<surname>Browne</surname>
<given-names>Caleb J</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7905-2000</contrib-id>
<name>
<surname>Nestler</surname>
<given-names>Eric J</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Telese</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8924-4447</contrib-id>
<name>
<surname>Williams</surname>
<given-names>Robert W</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>labwilliams@gmail.com</email>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2680-6921</contrib-id>
<name>
<surname>Chen</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>hchen@uthsc.edu</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0011qv509</institution-id><institution>University of Tennessee Health Science Center</institution></institution-wrap>, <city>Memphis</city>, <country country="US">United States</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>University of California San Diego</institution></institution-wrap>, <city>San Diego</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01yc7t268</institution-id><institution>Washington University in St. Louis</institution></institution-wrap>, <city>St Louis</city>, <country country="US">United States</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02erqft81</institution-id><institution>Marshall University</institution></institution-wrap>, <city>Huntington</city>, <country country="US">United States</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00k6tx165</institution-id><institution>Ball State University</institution></institution-wrap>, <city>Muncie</city>, <country country="US">United States</country></aff>
<aff id="a6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>University of Pennsylvania</institution></institution-wrap>, <city>Philadelphia</city>, <country country="US">United States</country></aff>
<aff id="a7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Flint</surname>
<given-names>Jonathan</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution>
</institution-wrap>
<city>Los Angeles</city>
<country country="US">United States</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Wassum</surname>
<given-names>Kate M</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution>
</institution-wrap>
<city>Los Angeles</city>
<country country="US">United States</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-11-13">
<day>13</day>
<month>11</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP108845</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-09-12">
<day>12</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-02-28">
<day>28</day>
<month>02</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.03.11.483993"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Lemen et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Lemen et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-108845-v1.pdf"/>
<abstract><p>Exploring the molecular genetic cascades responsible for behavioral responses to opioids can improve our understanding of drug use initiation. We generated high-precision time-series data for 105 morphine- and naloxone-related traits across ∼700 young adult BXD mice (64 diverse strains and both sexes) for 3 hours after a single morphine injection. Variations in responses were mapped using high precision sequencing-based genotypes. The initial locomotor responses to morphine map precisely to the µ opioid receptor gene (MOR or <italic>Oprm1</italic>) on chromosome (Chr) 10 with a peak linkage of 12.4 (–log<sub>10</sub>P). The <italic>B</italic> allele inherited from C57BL/6J is associated with up to 60% higher activity. This effect climaxes at 75 min but is exhausted by 160 min. A second major modulator of opioid activation emerges after about 100 min and is located on Chr 16 with peak linkages of 10.6 (–log<sub>10</sub>P) in females, also associated with a high <italic>B</italic> allele. This locus includes only one compelling candidate—<italic>fibroblast growth factor 12</italic> (<italic>Fgf12</italic>), a 600 Kb gene that controls sodium current kinetics at the axon hillock. A strong and transient epistatic interaction exists between the <italic>Oprm1</italic> and <italic>Fgf12</italic> loci during a short time window (45–75 min). The combination of a <italic>B</italic> haplotype at <italic>Oprm1</italic> with a <italic>D</italic> haplotype from DBA/2J at <italic>Fgf12</italic> is associated with unusually high activity. In a complementary study in heterogeneous stock rats we demonstrate that <italic>Oprm1</italic> and <italic>Fgf12</italic> are co-expressed in one specific subtype of <italic>Drd1</italic>+ medium spiny neuron. A Bayesian network analysis supports an <italic>Oprm1-</italic>to<italic>-Fgf12</italic> network that involves a <italic>MAP</italic> kinase cascade—<italic>Mapk8ip2</italic>, <italic>Map3k11</italic>, and <italic>Map3k12</italic>—that we hypothesize modulates <italic>FGF12</italic> phosphorylation, Nav1.2 sodium channel state, and locomotor activation. <italic>OPRM1</italic> and <italic>FGF12</italic> networks in human GWAS data highlight enrichment of signals associated with substance use disorder. This is the first demonstration of a time-dependent epistatic interaction modulating drug response in mammals and the first linkage of <italic>Fgf12</italic> to opioid sensitivity and potentially to sodium channel activity.</p>
</abstract>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>snRNA seq data, proposed underlying mechanism, Bayesian network update, author updates and additions, Multiple figures and supplementary files and figures updated.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Understanding the molecular genetics of opioids is crucial for treatment of opioid use disorder (OUD). Great progress has been made recently in genome-wide association studies (GWAS) of OUD. Genetic variants of several genes have reached genome-wide significance, such as <italic>KCNC1</italic>, <italic>KCNC2</italic> (<xref ref-type="bibr" rid="c31">Gelernter et al., 2014</xref>), <italic>CNIH3</italic> (<xref ref-type="bibr" rid="c53">Nelson et al., 2016</xref>), <italic>RGMA</italic> (<xref ref-type="bibr" rid="c13">Cheng et al., 2018</xref>), KDM4A (<xref ref-type="bibr" rid="c57">Sanchez-Roige et al., 2021</xref>), and <italic>OPRM1</italic> (<xref ref-type="bibr" rid="c79">Zhou et al., 2020</xref>). Recently, <xref ref-type="bibr" rid="c20">Deak and colleagues (2022)</xref> have identified an additional set of 19 independent risk loci for OUD. Most of these variants explain a relatively small fraction of the heritability of OUD and require validation.</p>
<p>The most replicated gene among these studies is the opioid receptor gene <italic>OPRM1</italic> (<xref ref-type="bibr" rid="c20">Deak et al., 2022</xref>; <xref ref-type="bibr" rid="c30">Gaddis et al., 2022</xref>; <xref ref-type="bibr" rid="c79">Zhou et al., 2020</xref>), which encodes the μ opioid receptor (MOR). Morphine, the prototypic MOR agonist, inhibits adenylyl cyclase and decreases the transmission of nociceptive information (<xref ref-type="bibr" rid="c76">Yam et al., 2018</xref>). Activation of MOR also increases dopaminergic neuronal transmission to the nucleus accumbens (NAc) by inhibiting GABAergic interneurons in the ventral tegmental area (VTA) (<xref ref-type="bibr" rid="c22">De Vries and Shippenberg, 2002</xref>). Coexpression of both MORs and dopamine D1 receptors (DRD1)—but not D2 receptors (DRD2)— is required for the initial locomotor response to morphine (<xref ref-type="bibr" rid="c61">Severino et al., 2020</xref>). MOR activation in striatal neurons is also a sufficient signal of opioid reward (<xref ref-type="bibr" rid="c19">Cui et al., 2014</xref>). However, the downstream molecular networks associated with <italic>OPRM1</italic> activation and signaling remain incompletely understood.</p>
<p>The lack of large and well phenotyped populations is a major impediment to further discovery of specific genes and mechanisms that modulate different phases of OUD (<xref ref-type="bibr" rid="c5">Berrettini, 2017</xref>). Compared to human GWAS, genetic mapping using model organisms requires a much smaller sample size. Phenotypes can be measured more accurately and studied mechanistically with better control over environmental variables. Large families of recombinant inbred strains (RI) are especially powerful for identifying genetic drivers responsible for trait variation, such as responses to opioids. These families are made by crossing two or more inbred strains, followed by intercrossing and inbreeding progeny for more than 20 generations (<xref ref-type="bibr" rid="c74">Williams et al., 2001</xref>). The BXD RI family of mice was created by crossing C57BL/6J (B6) with DBA/2J (D2) (<xref ref-type="bibr" rid="c2">Ashbrook et al., 2021</xref>; Taylor et al., 1999, 1973). This family has been used to study the effects of alcohol and many psychoactive drugs (Belknap et al., 1993; Crabbe, 1998; Crabbe et al., 1983; Miner and Marley, 1995), along with numerous other molecular and complex traits.</p>
<p>We generated, mapped, and analyzed data on variation in locomotor responses to morphine, and response to naloxone injection in the BXD family. The original data were described in <xref ref-type="bibr" rid="c55">Philip et al. (2010)</xref>, but here we greatly extended the analyses by using whole genome sequence-based genetic maps and the GEMMA linear mixed models for mapping (<xref ref-type="bibr" rid="c2">Ashbrook et al, 2021</xref>; Zhou and Stephens 2014). In addition to <italic>Oprm1,</italic> our analysis identified a new morphine response locus on chromosome 16 (Chr 16). We exploited complementary rodent data sets—both whole brain proteomics and single-nuclei RNAseq—and identified a new candidate gene—fibroblast growth factor 12 (<italic>Fgf12</italic>). We found a strong and transient epistatic interaction between the <italic>Oprm1</italic> and <italic>Fgf12</italic> loci in a short time window after morphine injection.</p>
<p>The snRNA-seq data highlights a single subtype of <italic>Drd1-</italic>positive cell type in which <italic>Oprm1</italic> and <italic>Fgf12</italic> are coexpressed. We then created a probabilistic causal model formalizing a molecular scheme in which gene variants modulate key signaling molecules to control locomotion after morphine injection. Lastly, we integrated rodent data with comparable human gene expression to provide a better translational context for understanding the molecular mechanisms and cellular cascades that may underlying initial variation in human OUD responses.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>QTL mapping of morphine-induced locomotor responses</title>
<p>A total of 64 fully inbred strains belonging to the BXD family (<xref ref-type="bibr" rid="c2">Ashbrook et al., 2021</xref>) were used, with each strain represented by balanced cohorts of approximately six males and six females (<xref ref-type="bibr" rid="c55">Philip et al., 2010</xref>). Locomotion was recorded for 180 min after an acute morphine injection, with movement data binned for each 15 min period. All data were generated by co-authors (PED, GM). Data for the 10th time bin (135–150 min) were lost and are not included in any analyses. Variation in locomotor responses revealed a skewed distribution (<xref ref-type="fig" rid="figs1">Supplementary Figure 1</xref>). We therefore quantile normalized data (<xref ref-type="fig" rid="figs2">Supplementary Figure 2</xref>) for most analyses, although we note that linkage statistics are robust with respect to this transformation.</p>
<p>QTL linkage was computed using a subset of informative sequenced-based markers using the latest version of GEMMA v0.98.5 (Prins et al., <ext-link ext-link-type="uri" xlink:href="https://github.com/genetics-statistics/GEMMA">github.com/genetics-statistics/GEMMA</ext-link>) as implemented in GeneNetwork. The genome-wide –log<sub>10</sub>P significance threshold (<italic>p</italic> &lt;0.05) for quantile normalized data is approximately 3.8 for the BXD family. A list of genome-wide significant loci for both morphine-induced locomotion and naloxone-induced withdrawal is summarized in <xref rid="tbl1" ref-type="table">Table 1</xref>, with more details provided in <xref rid="tbls1" ref-type="table">Supplementary Table 1</xref>.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><title>Genome-Wide Significant Loci for Morphine-Induced Locomotion or Naloxone-Induced Withdrawal</title></caption>
<graphic xlink:href="483993v3_tbl1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>Throughout the first two hours after injection of morphine (0–135 min bins) we detect a single and highly significant locus on Chr 10 (<xref rid="fig1" ref-type="fig">Figure 1</xref>) with peak linkage that extends from about 5.7 to 8.9 Mb in males and from 8.9 to 9.6 Mb in females, and maximal –log<sub>10</sub>P score of 10 and higher for males and 9.6 and higher for females (<xref rid="fig2" ref-type="fig">Figure 2</xref>) using quantile normalized locomotor data. This strong locus was reported by <xref ref-type="bibr" rid="c55">Philip et al. (2010)</xref>. But we also now detect a strong second locus for locomotor activation on Chr 16 between 25 and 30 Mb, that only emerges 90 minutes after injection, and that reaches its temporal peak more than two hours after injection (<xref rid="fig3" ref-type="fig">Figure 3</xref>). Linkage is significant in both sexes but is several orders of magnitude stronger in females than males—linkages of 10.6 and 4.28, respectively.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1:</label>
<caption><title>Time series of QTLs for morphine-induced locomotor response.</title>
<p>Locomotion data were quantile normalized and mapped against WGS-based genotype using GEMMA in <ext-link ext-link-type="uri" xlink:href="https://GeneNetwork.org">GeneNetwork.org</ext-link>. QTL for male <bold>(a)</bold> and female <bold>(b)</bold> are stacked up by increasing 15 min time intervals. The dotted lines represent the genome-wide significance level of ∼3.77. The color shaded areas indicate consistent associations across time bins for the Chr 10 locus (red) and the Chr 16 locus (blue). Strong correlation in morphine-induced locomotor response between male and female BXD strains shown in Pearson correlation scatterplots during the 45–60 min (<bold>c</bold>) and 165–180 min (<bold>d</bold>) time frames.</p></caption>
<graphic xlink:href="483993v3_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2:</label>
<caption><title>QTLs of morphine-induced locomotion between 45–60 min on Chr 10.</title>
<p><bold>(a)</bold> QTL for males with a peak –log<sub>10</sub>P of 10.06 (n = 63 strains). <bold>(b)</bold> QTL for females with a peak –log<sub>10</sub>P of 9.60 (n = 64 strains). <bold>(c)</bold> Zoomed-in view of QTL in males. <bold>(d)</bold> Zoomed-in view of QTL in females. <bold>(e)</bold> Cis-eQTL in the NAc of the BXDs, with a peak –log<sub>10</sub>P of 10.01 (n = 34 strains). <bold>(f)</bold> Cis-eQTL in the hippocampus of the BXDs, with a peak –log<sub>10</sub>P 9.7 (n = 67 strains) on Chr 10 at 5.6Mb. <bold>(g)</bold> <italic>Oprm1</italic> neighborhood in BXD family with SNP densities. <bold>(h)</bold> Map of Haplotypes showing gene expression. The “B” of BXD is the mother, and “D” is the father. GEMMA with LOCO was used for all association mapping.</p></caption>
<graphic xlink:href="483993v3_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3:</label>
<caption><title>QTLs of morphine-induced locomotion between 165–180 min on Chr 16.</title>
<p><bold>(a)</bold> QTL in males with a peak –log<sub>10</sub>P of 4.28 (n = 63 strains). <bold>(b)</bold> QTL for females with a peak –log<sub>10</sub>P of 10.56 (n = 64 strains). <bold>(c)</bold> Zoomed-in view of the QTL in males. <bold>(d)</bold> Zoomed-in view of the QTL in females. <bold>(e)</bold> Cis-eQTL in the striatum of the BXDs, with a peak –log<sub>10</sub>P of 4.43. <bold>(f)</bold> Cis-eQTL in the VTA of the BXDs, with a peak –log<sub>10</sub>P of 4.06. <bold>(g)</bold> Histogram of the normalized expression of <italic>Fgf12</italic> in striatum and zoomed in view of the QTL region. <bold>(h)</bold> Histogram of the normalized expression of <italic>Fgf12</italic> in VTA and zoomed in view of the QTL region. GEMMA with LOCO was used for all association mapping.</p></caption>
<graphic xlink:href="483993v3_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Males and females display roughly similar patterns of linkage on both Chr 10 and Chr 16. This is consistent with the generally strong positive sex correlations in morphine-induced locomotion responses across all 15-minute intervals. Correlation coefficients peak at about 0.84 to 0.88 from 15 to 75 minutes after injection—the phase during which morphine induces the steepest increase in locomotion—from about 29 to 71 m per 15 min bin (<xref rid="fig1" ref-type="fig">Figure 1c-d</xref>). This is also the interval that corresponds to the peak linkage in both sexes near <italic>Oprm1</italic>. Thereafter, correlations drop but are still generally above 0.70 through to 120 min. During the last hour correlations are lower—ranging from 0.57 to 0.68. This drop in correlation corresponds to the period during which effects of the <italic>Fgf12</italic> locus are strongest, and conversely, effects of the <italic>Oprm1</italic> locus are weakest. The distance traveled in the final interval (165 to 180 min) is down to a level slightly lower than that in the first interval—about 25 meters—and the final correlation between sexes is 0.68. This is the interval during which the <italic>Fgf12</italic> locus has a remarkably high linkage of 9.7 and 5.3 in females and males, respectively. In contrast, at this late stage <italic>Oprm1</italic> has linkage below 2.5 in both sexes.</p>
</sec>
<sec id="s2b">
<title>Candidate gene identification for morphine-induced locomotor response</title>
<p>The mu 1 opioid receptor protein (MOR or OPRM1) is expressed in multiple brain regions and is involved in opioid-induced reward and locomotor response (<xref ref-type="bibr" rid="c15">Contet et al., 2004</xref>). In mice the very large <italic>Oprm1</italic> gene is on Chr 10 between 6.76 and 7.04 Mb, just proximal to the linkage peak (<xref rid="fig2" ref-type="fig">Figure 2c-d</xref>, GRCm38 assembly). In the BXD family there are over 40 known SNPs, indels, and larger variants segregating in this gene locus, but to the best of our knowledge none alter protein sequence. Given its location just proximal to the QTL peak, its large size, and the high level of genetic variation, <italic>Oprm1</italic> is an uncontroversial candidate for differences in acute morphine locomotor activation (<xref rid="tbl2" ref-type="table">Table 2</xref>). But there is some additional support—expression of <italic>Oprm1</italic> mRNA has been quantified in many brain regions across the BXD family, and variants in and around this gene clearly modulate its expression most strongly in nucleus accumbens (NAc) and hippocampus (cis-eQTLs with –logP values &gt;7.0, see examples in <xref rid="fig2" ref-type="fig">Figure 2e,f</xref>). Variation in the expression levels of <italic>Oprm1</italic> from the <italic>B</italic> and <italic>D</italic> haplotypes could contribute causally to the Chr 10 locus. Of functional importance, the <italic>D</italic> allele has roughly 50% higher expression in both NAc (<xref rid="fig2" ref-type="fig">Figure 2e</xref>) and hippocampus (<xref rid="fig2" ref-type="fig">Figure 2f</xref>), an interesting observation given that BXD strains that inherit the <italic>B</italic> allele tend to have a much stronger initial locomotor response.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><title>List of Candidate Genes</title></caption>
<graphic xlink:href="483993v3_tbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>We restricted our analysis of candidate genes for the novel Chr 16 locus to a 1.5 –logP confidence interval extending from 27 to 29 Mb (<xref rid="fig1" ref-type="fig">Figure 1</xref>). This small region contains only five protein-coding genes and one gene model (<italic>Gm10823</italic>) in the following proximal-distal order: <italic>Ostn, Uts2d</italic>, <italic>Ccdc50</italic>, <italic>Gm10823</italic>, <italic>Fgf12</italic>, and <italic>Mb21d2</italic> (<xref rid="fig4" ref-type="fig">Figure 4</xref>). <italic>Fgf12</italic>, previously known as <italic>Fhf1</italic>, is by far the largest protein-coding gene in this interval (∼600 Kb), with a promoter located close to <italic>Mb21d2</italic> (<xref rid="fig3" ref-type="fig">Figures 3c–d</xref>, <xref rid="fig4" ref-type="fig">Figure 4</xref>). This is also the strongest biological candidate gene, and is already known to interact with the C-terminal region of three sodium channel proteins— SCN9A (<xref ref-type="bibr" rid="c73">Wildburger et al., 2015</xref>), SCN8A (<xref ref-type="bibr" rid="c44">Liu et al., 2003</xref>), and SCN2A (<xref ref-type="bibr" rid="c73">Wildburger et al., 2015</xref>). <italic>Fgf12</italic> encodes a protein that is a member of the fibroblast growth factor (FGF) family. FGFs are involved in response to alcohol (<xref ref-type="bibr" rid="c27">Even-Chen et al., 2017</xref>) and morphine (<xref ref-type="bibr" rid="c29">Flores et al., 2010</xref>) in key brain reward regions. A list of candidate genes is provided in <xref rid="tbl2" ref-type="table">Table 2</xref>.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4:</label>
<caption><title>Chr 16 locus at 165-180 min after morphine injection.</title>
<p><bold>(a)</bold> Zoomed in view of the Chr 16 locus, from 26-29 Mb, showing individual SNPs (blue dots) and genes (purple horizontal lines) in the region. <bold>(b)</bold> A screenshot of GeneNetwork showing SNPs that inhabit this region. Almost all B vs D SNPs (orange hash along x-axis) are restricted to two regions.</p></caption>
<graphic xlink:href="483993v3_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The majority of the <italic>Fgf12</italic> gene is situated in a region that is almost identical-by-descent between the <italic>B</italic> and <italic>D</italic> parental haplotypes. This is highlighted in <xref rid="fig4" ref-type="fig">Figure 4</xref> as the very low SNP density. There are a 12 known non-coding variants between <italic>B</italic> and <italic>D</italic> haplotypes, and no known coding variants, however, there are very significant cis-acting expression QTLs associated with <italic>Fgf12</italic> expression differences in the striatum (<xref rid="fig3" ref-type="fig">Figure 3e,g</xref>, –logP of 4.4) and the ventral tegmental area (<xref rid="fig3" ref-type="fig">Figure 3f</xref>, h –logP of 4.1). The <italic>B</italic> allele is associated with expression that is as much as 60% higher than that of the <italic>D</italic> allele.</p>
</sec>
<sec id="s2c">
<title>An epistatic interaction between <italic>Oprm1</italic> and <italic>Fgf12</italic> loci modulates locomotor response to morphine</title>
<p>We detect large additive effects for the locomotor responses to morphine near <italic>Oprm1</italic> at early time points (0–90 min) and near to <italic>Fgf12</italic> at late time points (+90 min). We tested for a possible epistatic interaction between these distinct loci and discovered a strong but transient interaction in both sexes (<xref rid="fig6" ref-type="fig">Figure 6</xref>). The epistasis is strongest in the 45–60 min period—precisely at the midpoint between the early and additive <italic>Oprm1</italic> effect and the late and additive <italic>Fgf12</italic> effect (<xref rid="fig8" ref-type="fig">Fig 8c-g</xref>, e.g., male trait BXD_11331). Those BXDs that inherit the <italic>B</italic> haplotype of <italic>Oprm1</italic> (defined as rs29339674, 6.7 Mb) as well as the <italic>D</italic> haplotype of the <italic>Fgf12</italic> locus (defined as rs4169220 at 31.6 Mb) have unexpectedly high levels of locomotion compared to all of the other two-locus combinations (<xref rid="fig6" ref-type="fig">Figure 6</xref>). The –logP value of the epistatic component is in the range of 2.5-4.8 (MF = trait BXD_11845, –logP = 4.2; F trait = BXD_11588, –logP = 4.8; M trait = BXD_11331, –logP = 2.5) and is significant by permutation testing at a genome-wide threshold of 0.05. The full model that includes this interaction term, as well as both additive effects at <italic>Oprm1</italic> and at <italic>Fgf12</italic> has a remarkably high –logP value of 11.9-13.2 (MF = 13.2, F = 11.9, M = 12.0). This epistatic interaction is preserved as the time window moves forward. For example, maps of the 60–75 min interval (trait BXD_18846) has an epistatic effect with a –logP of 3.0; an additive effect near <italic>Oprm1</italic> with a –logP of 8.2; and an additive effect at <italic>Fgf12</italic> of merely 0.14. The full model in this interval still has a very high cumulative –logP of 11.4. By 75–90 minutes (trait BXD_18847) the interaction effect has dropped to a –logP of 2.2 and the model has a cumulative –logP of 9.40. In marked contrast, over the two intervals from 90 <italic>to</italic> 120 minutes we do not detect significant epistasis. At best, the interaction –logP is only in the range of 1.5–2.0. In the 120–135 and 150–165 minute intervals the originally powerful <italic>Oprm1</italic> additive effect has faded to 2.74 and 1.15, respectively. There is no detectable interaction with the <italic>Fgf12</italic> locus. However, the purely additive effect at <italic>Fgf12</italic> is now much stronger and is detectable for the first time as an independent additive effect with –logP values of 2.1 and 4.2, respectively. Finally, in the last interval—165–180 minutes (trait BXD_11585)—we detect no linkage to the <italic>Oprm1</italic> locus, or any epistasis, but we again pick up a highly significant additive effect at the <italic>Fgf12</italic> locus with a peak –logP that is 4.9.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5:</label>
<caption><title>Epistatic Interaction Among Genotype Combinations.</title>
<p><bold>(a)</bold> Males and <bold>(b)</bold> females with different combinations of the “<italic>B</italic>” (i.e., <italic>B/B</italic>) or “<italic>D</italic>” (i.e. <italic>D/D</italic>) genotypes yield different distances traveled after morphine injection over 120 mins. Distance traveled (m) between the two genotypes for each loci is shown for each timepoint in <bold>(c-f)</bold> males and <bold>(g-j)</bold> females.</p></caption>
<graphic xlink:href="483993v3_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title><italic>Oprm1</italic> and <italic>Fgf12</italic> are positively correlated in rat NAc suggested by snRNA-seq.</title>
<p><bold>(a)</bold> UMAP visualization of cell clusters from 4495 nuclei from rat nucleus accumbens core. <bold>(b)</bold> Dot plot showing the expression level of cell type marker genes in cell clusters. The shade of dots denotes normalized and scaled average expression and the size of dots denotes the percentage of cells expressing the gene in each cell cluster. <bold>(c-d)</bold> Violin plots indicating the normalized and scaled expression level of <italic>Oprm1</italic> <bold>(c)</bold> and <italic>Fgf12</italic> <bold>(d)</bold> across cell clusters. <bold>(e-g)</bold> Scatter plots showing the correlation relationship between <italic>Oprm1</italic> and <italic>Fgf12</italic> in all cells <bold>(e)</bold>, D1-MSN-3 <bold>(f)</bold>, and D1-MSN-2 <bold>(g)</bold>. Nuclei counts (n), Pearson’s correlation coefficients (r), and p-values (p) are labeled on each panel. UMAP, Uniform Manifold Approximation and Projection; D1-MSN, Drd1-expressing medium spiny neuron; D2-MSN, Drd2-expressing medium spiny neuron; GABA, GABAergic inhibitory neuron; Glut, glutamatergic excitatory neuron; Ol, oligodendrocyte; OPC, oligodendrocyte precursor cell; Ast, astrocyte, Mg, microglial cells</p></caption>
<graphic xlink:href="483993v3_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>Cell-type-specific co-expression of <italic>Oprm1</italic> and <italic>Fgf12</italic> in the rat nucleus accumbens core</title>
<p>To further examine whether <italic>Oprm1</italic> and <italic>Fgf12</italic> were co-expressed in the same cells of the NAc, we performed snRNA-seq using a droplet-based approach (10X Genomics). Nuclei were isolated from microdissected NAc cores obtained from two female heterogeneous stock (HS) rats (<xref ref-type="bibr" rid="c12">Carrette et al., 2021</xref>). After filtering out low-quality nuclei and potential doublets, a total number of 4,495 high-quality nuclei transcriptomes remained with a median number of 3,363 transcripts (unique molecular identifiers) and 1,861 genes detected per nucleus. We then performed SCT transformation (<xref ref-type="bibr" rid="c37">Hafemeister and Satija, 2019</xref>), dimensional reduction, and clustering using Seurat (<xref ref-type="bibr" rid="c65">Stuart et al., 2019</xref>) and identified 17 cell-type clusters (<xref rid="fig7" ref-type="fig">Figure 7a</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7:</label>
<caption><title>Modeling the mechanistic interactions between genetic variants and phenotypes using Bayesian network.</title>
<p>This network illustrates the relationship between genetic variants in the Chr 10 and Chr 16 QTL regions and the differential expression of candidate genes <italic>Oprm1</italic> and <italic>Fgf12</italic> in the BXD family. Additional gene expression data of MAP kinases were retrieved from <ext-link ext-link-type="uri" xlink:href="https://GeneNetwork.org">GeneNetwork.org</ext-link>. Morphine induced locomotion responses at different time bins are also included in the network. This causal hypothesis was developed using the Bayesian network framework available in Genenetwork, where the arrow is indicative of the direction of the causal relationship. Additional genes included in the input of the network construction but had no connection to the final network were excluded in the illustration.</p></caption>
<graphic xlink:href="483993v3_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We annotated the cell clusters based on the expression level of established marker genes of the major cell types: neurons (<italic>Snap25, Syt1</italic>), excitatory neurons (<italic>Slc17a7</italic>), inhibitory neurons (<italic>Gad1</italic>), dopaminergic neurons (<italic>Ppp1r1b, Foxp2, Blc11b</italic>), oligodendrocytes (<italic>Mbp</italic>), oligodendrocyte precursor cells (<italic>Pdgfra</italic>), astrocytes (<italic>Aqp4</italic>), and microglia (<italic>Arhgap15</italic>). In addition, we identified 7 subtypes of dopaminergic-receptor neurons. We used expression of <italic>Drd1</italic> and <italic>Tac1</italic> to define D1-type medium spiny neurons (D1-MSNs) and <italic>Drd2</italic> and <italic>Penk</italic> to define D2-type medium spiny neurons (D2-MSNs) (<xref rid="fig7" ref-type="fig">Figure 7b</xref>, n = 1,768 MSNs total, see <xref ref-type="fig" rid="figs4">Supplementary Figure 4f</xref>). MSNs represented the majority (91.8%) of neuronal cells, as expected by previous knowledge of the NAc cellular composition.</p>
<p><italic>Oprm1</italic> was uniquely expressed in the D1-MSN-3 subtype, while <italic>Fgf12</italic> was expressed across all cell populations (<xref rid="fig7" ref-type="fig">Figure 7c,d</xref>). Pearson’s correlation analysis using expression data from every cell type conveyed a weak but significant positive correlation (<italic>r</italic> = 0.08, <italic>p</italic> = 1.8e-8) between the expression of <italic>Oprm1</italic> and <italic>Fgf12</italic> (<xref rid="fig7" ref-type="fig">Figure 7e</xref>). When we performed Pearson’s correlation analysis within each individual cell cluster, only D1-MSN-3 had a significant positive correlation (<italic>r</italic> = 0.35, <italic>p</italic> = 6.1e-8, <xref rid="fig7" ref-type="fig">Figure 7f</xref>). In contrast, D1-MSN-2 had a significant weak negative correlation (<italic>r</italic> = –0.12, <italic>p</italic> = 0.02, <xref rid="fig7" ref-type="fig">Figure 7g</xref>). In conclusion, D1-MSN-3 is the only cell cluster expressing a high level of <italic>Oprm1</italic> in rat NAc, in which the expression levels of <italic>Oprm1</italic> and <italic>Fgf12</italic> are significantly and positively correlated.</p>
</sec>
<sec id="s2e">
<title>Constructing and testing Bayesian networks</title>
<p>We hypothesize that genetic variants in the Chr 10 and Chr 16 QTL regions are driving differential expression of <italic>Oprm1</italic> and <italic>Fgf12</italic> in the BXD family and thereby modulating morphine-induced locomotor responses. We used the literature to guide our selection of mediators acting between <italic>Oprm1</italic> and <italic>Fgf12</italic> (<xref ref-type="bibr" rid="c6">Bhushan et al., 2017</xref>; <xref ref-type="bibr" rid="c8">Buchsbaum et al., 2002</xref>). For example, <italic>FGF12</italic> (<xref ref-type="bibr" rid="c64">Sochacka et al., 2020</xref>) and <italic>MAPK8IP2</italic> are linked to a few sodium channel components—SCN2A (NAv1.2) and SCN8A (NAv1.6)(<xref ref-type="bibr" rid="c59">Schoorlemmer and Goldfarb, 2001</xref>; <xref ref-type="bibr" rid="c60">Seiffert et al., 2022</xref>)—as part of a membrane-associated scaffold concentrated at the axon hillock. The <italic>MAPK8IP2</italic> scaffold protein is thought to modulate JUN amino-terminal kinase signaling, and also interacts with and controls the activity of MAPK8/JNK1 and MAP2K7/MKK7 (<xref ref-type="bibr" rid="c54">O’Leary et al., 2016</xref>).</p>
<p>We tested <italic>Scn2a, Scn8a, Map3k11</italic>, <italic>Map3k12</italic>, and <italic>Mapk8ip2</italic> as candidate mediators of the <italic>Oprm1</italic> and <italic>Fgf12</italic> loci and variation in locomotor activity. Expression levels of these transcripts in striatum, VTA, and NAc of BXD strains were passed from GeneNetwork into the Bayesian Network (BN) Webserver (<xref ref-type="bibr" rid="c80">Ziebarth and Cui, 2017</xref>) to define the most probable network structure. We constrained the nodes into four tiers: Tier 1 contains the two loci as instrumental variables; tier 2 contains expression estimates of the two prime candidate genes, <italic>Oprm1</italic> and <italic>Fgf12</italic>; tier 3 contains the sodium channels and MAP kinases that potentially mediate both additive and epistatic effects on locomotion; and tier 4 contains the locomotor outcomes expressed in four time-series bins.</p>
<p>The most strongly supported model (<xref rid="fig8" ref-type="fig">Figure 8</xref>) recapitulated the cis-eQTL results by indicating that the Chr 10 and Chr 16 loci control the expression of <italic>Oprm1</italic> and <italic>Fgf12</italic> mRNA. This model also supports the causal role of <italic>Oprm1</italic> and its downstream MAP kinases on locomotor response during the first 120 minutes after injection. In contrast, the last 45 minutes are dominated by a direct <italic>Fgf12</italic> effect. Further, <italic>Oprm1</italic> and <italic>Fgf12</italic> directly modulate <italic>Map3k11</italic>, which in turn modulates <italic>Mapk8ip2</italic> and <italic>Map3k12</italic> mRNA expression and regulate locomotion from 0 to 75 min. Further, Mapk8ip2 is embedded in this network with multiple connections.</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8:</label>
<caption><title>QTLs for naloxone-induced morphine withdrawal responses in males and female BXD mice.</title>
<p>Behavior data were quantile normalized and mapped against WGS-based genotypes using GEMMA in <ext-link ext-link-type="uri" xlink:href="https://GeneNetwork.org">GeneNetwork.org</ext-link>. <bold>(a)</bold> Number of jumps 15 minutes after naloxone injection in males. <bold>(b)</bold> Number of jumps 15 minutes after naloxone injection in females. <bold>(c)</bold> Change in locomotion measured by the last 15 min of morphine locomotion response minus the first 15 min after naloxone injection in males, with a peak on Chr 10 and a peak on Chr 16 <bold>(d)</bold> Change in locomotion measured by the last 15 min of morphine locomotion response minus the first 15 min after naloxone injection in females, with a peak on Chr 16. <bold>(e)</bold> Horizontal activity (distance traveled) 0–15 min after naloxone injection for males. <bold>(f)</bold> Horizontal activity (distance traveled) 0–15 min after naloxone injection for females, with a peak on Chr 6, and a peak on Chr 12. <bold>(g)</bold> Number of beam breaks in an open field 0–15 min after naloxone injection in females, with a peak on Chr 6 and a peak on Chr 12. <bold>(h)</bold> Salivation level in females. Dashed lines: genome wide significance threshold. Dotted lines: threshold for suggestive significance.</p></caption>
<graphic xlink:href="483993v3_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>This Bayesian network aligns well with whole-brain proteomics data (<xref ref-type="fig" rid="figs5">supplementary figure 5</xref>). In agreement with the mRNA data, <italic>Oprm1</italic> and <italic>Fgf12</italic> are expressed with opposite polarities, in which the <italic>B</italic> allele is associated with high expression of <italic>Oprm1</italic> and low expression of <italic>Fgf12</italic> and vice versa for the <italic>D</italic> allele. The three MAP kinases are also expressed in higher levels in animals that inherit <italic>B</italic> alleles than <italic>D</italic> alleles.</p>
</sec>
<sec id="s2f">
<title>QTL mapping of naloxone-induced withdrawal responses</title>
<p>After the morphine locomotion tests were complete, naloxone was injected (30 mg/kg in isotonic saline at a volume of 10 ml/kg) to induce a morphine withdrawal response (<xref ref-type="bibr" rid="c55">Philip et al., 2010</xref>). Locomotion and other behavioral measurements were taken for both males and females. QTL analysis of these traits were not included in <xref ref-type="bibr" rid="c55">Philip et al. (2010)</xref>. There are an impressive 16 genome-wide significant QTLs among 5 naloxone-induced withdrawal behavioral responses (<xref rid="fig8" ref-type="fig">Figure 8</xref>, <xref ref-type="table" rid="tbls1">Supplementary Table 1</xref>).</p>
<p><xref rid="fig8" ref-type="fig">Figure 8c-d</xref> displays the differences in locomotion before and after naloxone injection, with a QTL peak on Chr 10 and 16 that overlap the morphine locomotor QTLs in <xref rid="fig2" ref-type="fig">Figures 2</xref> and <xref rid="fig3" ref-type="fig">3</xref> and that are likely to correspond to variants in or near to <italic>Oprm1</italic> and <italic>Fgf12</italic>. Our results show that the genotype effect on locomotion was similar before and after naloxone injection (<xref ref-type="fig" rid="figs7">Supplementary Figure 7</xref>). We evaluated the biological function of naloxone candidate genes using GeneCup (<xref ref-type="bibr" rid="c36">Gunturkun et al., 2022</xref>). Candidates for the locus on Chr 14 for naloxone-induced jumps include <italic>Slc7a7</italic> and <italic>Slc7a8</italic> (<xref rid="tbl2" ref-type="table">Table 2</xref>). Both are transmembrane amino acid transporter proteins (<xref ref-type="bibr" rid="c40">Hu et al., 2020</xref>) that dimerize with <italic>SLC3A2(</italic><xref ref-type="bibr" rid="c41">Hurkmans et al., 2022</xref><italic>; </italic><xref ref-type="bibr" rid="c68">Torrents et al., 1999</xref><italic>, </italic><xref ref-type="bibr" rid="c67">1998</xref><italic>)</italic>. Of relevance, <italic>SLC7A8</italic> (LAT2) is an L-DOPA transporter(<xref ref-type="bibr" rid="c18">Crocco et al., 2024</xref>).</p>
</sec>
<sec id="s2g">
<title>Integrating murine data with human GWAS results</title>
<p>There is support for our results in human GWAS of OUD. <italic>OPRM1</italic> variant rs179971 has been associated with OUD in the first well-powered meta-analysis (<xref ref-type="bibr" rid="c79">Zhou et al., 2020</xref>) and confirmed in a recent study (<xref ref-type="bibr" rid="c38">Hatoum et al., 2022a</xref>). A human GWAS of opioid cessation reported linkage to the FGF signaling pathway in which the effect of <italic>FGF12</italic> was nominally significant (<italic>p</italic> = 0.0015, odd ratio = 1.24) (<xref ref-type="bibr" rid="c16">Cox et al., 2020</xref>). In gene-based analyses by <xref ref-type="bibr" rid="c20">Deak et al. (2022)</xref> for OUD, there was a significant signal at <italic>FGF12</italic> (<italic>p</italic> = 0.006).</p>
<p>Considering the epistatic interaction between <italic>OPRM1</italic> and <italic>FGF12</italic> and the complexity of human genetic signals (many genes of small effects) it is possible that these two genes function in a network that contains many other genes. We thus developed a list of 500 genes that overlap with <italic>FGF12</italic> and <italic>OPRM1</italic> in the GTEx sample (<xref ref-type="bibr" rid="c34">GTEx Consortium, 2013</xref>) (GTEx v8). We then examined whether there is enrichment of members of this network using MAGMA (<xref ref-type="bibr" rid="c21">de Leeuw et al., 2015</xref>) in the GWAS by <xref ref-type="bibr" rid="c79">Zhou et al.(2020)</xref>. Our initial analysis was performed for NAc, putamen, caudate, and adipose tissue for the <italic>FGF12</italic> lists (the latter as a negative control).</p>
<p>For OUD, no significant enrichment was observed for the original 500-gene lists, likely due to the lists’ large size and the limited statistical power of the SUD GWAS. In the GWAS conducted by <xref ref-type="bibr" rid="c20">Deak et al. (2022)</xref>, where <italic>FGF12</italic> was nominally significant, we found nominally significant enrichment in two of the brain regions, putamen and caudate. Given the low power of this dataset and the broad initial gene list, we refined our analysis to focus on genes specifically correlated with <italic>OPRM1</italic> and <italic>FGF12</italic> in relevant tissues (see Methods). No enrichment was observed for the gene network in the OUD GWAS (p = 0.493). However, this refined approach revealed nominal enrichment (p = 0.038) for the addiction risk factor (<xref ref-type="bibr" rid="c39">Hatoum et al., 2022b</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>We analyzed time-dependent behavioral responses to morphine and naloxone collected from the BXD family of mice (<xref ref-type="bibr" rid="c55">Philip et al., 2010</xref>) using WGS-based genetic markers and linear mixed models. We discovered a novel association on a Chr 16 locus that overlaps <italic>Fgf12</italic> in both sexes, in addition to confirming an association between locomotor response and a region on Chr 10 that overlaps <italic>Oprm1</italic>. Further, these two loci had a significant but transient epistatic interaction between 45–90 min after morphine injection. According to our transcriptomic data from NAc in rats, <italic>Oprm1</italic> and <italic>Fgf12</italic> are colocalized in a specific subtype of D1-MSN and their expression levels are positively correlated. Analysis of both <italic>OPRM1</italic> and <italic>FGF12</italic> in human GWAS data demonstrated an enrichment of signals associated with SUD phenotypes, and a modest corroboration of variants in the <italic>FGF12</italic> locus on Chr 3q28.</p>
<sec id="s3a">
<title>Additive effect of the <italic>Oprm1</italic> locus</title>
<p>The proximal Chr10 locus associated with early phase locomotor response to morphine contains the <italic>Oprm1</italic> gene. This locus has been associated with the antinociceptive effect of morphine (<xref ref-type="bibr" rid="c4">Bergeson et al., 2001</xref>). <italic>Oprm1</italic> encodes the primary receptor responsible for morphine-induced locomotor response (<xref ref-type="bibr" rid="c61">Severino et al., 2020</xref>; <xref ref-type="bibr" rid="c63">Smith et al., 2009</xref>), and is also responsible for its addiction liability (<xref ref-type="bibr" rid="c3">Ballester et al., 2022</xref>; <xref ref-type="bibr" rid="c78">Zhang et al., 2020</xref>). Morphine-induced locomotion was affected by <italic>Oprm1</italic> variants (<xref ref-type="bibr" rid="c56">Popova et al., 2019</xref>). For example, in the <italic>Oprm1</italic> A112G knock-in mouse, morphine-induced hyperactivity was blunted (<xref ref-type="bibr" rid="c46">Mague et al., 2009</xref>). Further, the effect of MOR on locomotion depends on the neuronal cell types involved. For example, when MOR was deleted from D1 neurons, mice had hyperlocomotion in response to opioids. By contrast, when MOR was deleted from A2a (adenosine A2a receptor-expressing) neurons, mice displayed increased movement in response to opioids (<xref ref-type="bibr" rid="c61">Severino et al., 2020</xref>). These data indicate that <italic>Oprm1</italic> is a strong candidate gene for the Chr 10 locus associated with morphine-induced locomotion response.</p>
<p>BXDs with the <italic>D</italic> allele at the <italic>Oprm1</italic> locus were less sensitive to a 50 mg/kg dose of morphine (<xref rid="fig6" ref-type="fig">Figure 6</xref>). The locomotion data demonstrate a blunted motor activity response similar to what was seen in low doses of morphine (5 to 10 mg/kg) (<xref ref-type="bibr" rid="c50">Mori et al., 2004</xref>), while BXDs with the <italic>B</italic> allele demonstrate higher sensitivity at the same dose; strains with the <italic>B</italic> allele had an initial biphasic increase in motor activity followed by a drop. This suggests that the <italic>B</italic> allele of <italic>Oprm1</italic> is associated with greater sensitivity or locomotion activity. These data match the differences between the parents of the BXD family. The locomotor response to morphine in C57BL/6J is more pronounced and lasts longer compared to that of DBA/2J (<xref ref-type="bibr" rid="c52">Murphy et al., 2001</xref>). This is also accompanied by greater morphine-induced dopamine release in the NAc in C57BL/6J than in DBA/2J mice (<xref ref-type="bibr" rid="c52">Murphy et al., 2001</xref>). It is likely that differences in morphine-induced dopamine release are involved in the highly variable locomotor responses to morphine across the BXD family.</p>
</sec>
<sec id="s3b">
<title>Additive effect of the <italic>Fgf12</italic> locus</title>
<p>The association between the Chr 16 locus (<xref rid="fig1" ref-type="fig">Figure 1</xref> a,b) and morphine-induced locomotion 150–180 minutes after injection is a novel finding, as is the detection of a time-delimited epistatic interaction of the Chr 16 locus with the <italic>Oprm1</italic> locus. Of all positional candidate genes in the Chr 16 locus (<xref rid="fig4" ref-type="fig">Figure 4</xref>), <italic>Fgf12</italic> was the most biologically relevant and was supported by strong cis-eQTL in striatum and VTA (<xref rid="fig3" ref-type="fig">Figure 3</xref> e,f). Studies have implicated members of the FGF family, such as <italic>Fgf2</italic> (<xref ref-type="bibr" rid="c25">Even-Chen and Barak, 2019a</xref>), FGF receptor 1 (<xref ref-type="bibr" rid="c26">Even-Chen and Barak, 2019b</xref>), and FGF receptor 2 (<xref ref-type="bibr" rid="c7">Blackwood et al., 2019</xref>) in substance use. It has recently been demonstrated that administration of an <italic>Fgf21</italic> analog in non-human primates decreased alcohol consumption by 50% via an amygdala-striatal circuit (<xref ref-type="bibr" rid="c28">Flippo et al., 2022</xref>). Unlike these secreted FGFs, <italic>Fgf12</italic> is an intracellular protein that serves as a cofactor for voltage-gated sodium channels and other molecules and is involved in intracellular signaling events (<xref ref-type="bibr" rid="c59">Schoorlemmer and Goldfarb, 2001</xref>). While the full spectrum of its function remains unknown, <italic>Fgf12</italic> has demonstrated a role in locomotion. For example, mice with a null mutation of <italic>Fgf12</italic> have ataxia (<xref ref-type="bibr" rid="c33">Goldfarb et al., 2007</xref>). Elevated stress responses have been associated with a reduction in <italic>Fgf12</italic> expression in the prefrontal cortex in rats (<xref ref-type="bibr" rid="c47">McCreary et al., 2016</xref>). <italic>FGF12</italic> expression is also elevated in the anterior cingulate cortex of patients with major depressive disorder (<xref ref-type="bibr" rid="c24">Evans et al., 2004</xref>). Variants in human <italic>FGF12</italic> have been linked to cognitive decline (<xref ref-type="bibr" rid="c49">Mohammadnejad et al., 2020</xref>), major depression (<xref ref-type="bibr" rid="c32">GENDEP Investigators et al., 2013</xref>), and sleep quality (<xref ref-type="bibr" rid="c9">Byrne et al., 2013</xref>) in the GWAS Catalog.</p>
</sec>
<sec id="s3c">
<title>The epistasis of morphine locomotor activation</title>
<p>We identified a highly significant epistatic interaction between the <italic>Oprm1</italic> and <italic>Fgf12</italic> loci but only 45–90 min after morphine injection (<xref rid="fig6" ref-type="fig">Figure 6</xref>). Those strains that inherit both the <italic>B/B</italic> genotype at <italic>Oprm1</italic> and the <italic>D</italic>/D genotype at <italic>Fgf12</italic> have significantly higher activity levels compared to those strains that inherit the other three genotype combinations. Our mapping extends in intervals of 15 minutes over a 3 hour period. We can divide this interval into four phases (<xref rid="fig1" ref-type="fig">Figure 1</xref>).The first phase after the morphine injection is influenced only by DNA variants in the <italic>Oprm1</italic> locus. The second phase— from 45 to 90 minutes—is characterized by the strong but transient epistatic interaction of <italic>Oprm1</italic> and <italic>Fgf12</italic> loci. The third phase is a kind of hiatus that extends from 90 to 120 minutes in which we do not detect any epistatic interactions. Only <italic>Oprm1</italic> is active during this phase. In the final phase—from 120 to 180 minutes—the <italic>Oprm1</italic> effect is exhausted and now the <italic>Fgf12</italic> locus acts independently for the first time with a purely additive effect on activity. The hiatus phase may be explained mechanistically by effects of other loci that we are not yet able to detect reliably. Note for example the transient female-specific locus on Chr 5 that fills part of the hiatus. This complex time course of transitioning in genetic control on morphine induced locomotion is likely caused by molecular cascades triggered by the activation of the <italic>OPRM1</italic> receptor and its signalling molecules and downstream molecular network linked to <italic>FGF12</italic>. To some extent we have tried to bridge the gap between the genetics of morphine responses to possible molecular cascades using Bayesian causal modeling as in <xref rid="fig8" ref-type="fig">Figure 8</xref>.</p>
<p>Complex traits, such as OUD, are controlled by many genes that interact with each other and their environment (<xref ref-type="bibr" rid="c17">Crist et al., 2019</xref>). While improved statistical approaches (<xref ref-type="bibr" rid="c23">D’Silva et al., 2022</xref>; <xref ref-type="bibr" rid="c72">Wei et al., 2014</xref>) and novel machine learning methods (<xref ref-type="bibr" rid="c14">Chicco and Faultless, 2021</xref>) are starting to enable the study of epistasis in human data, most human genetic studies either did not have the power to detect epistasis or ignored its effect (<xref ref-type="bibr" rid="c11">Carlborg and Haley, 2004</xref>; <xref ref-type="bibr" rid="c69">Uffelmann et al., 2021</xref>). In contrast, many epistatic interactions have been identified using model organisms (<xref ref-type="bibr" rid="c45">Mackay, 2014</xref>), mostly due to the ability to obtain data from individuals with controlled genotypes and measuring phenotypes in well controlled environments (<xref ref-type="bibr" rid="c10">Campbell et al., 2018</xref>). Identifying gene-gene interactions in model organisms can provide candidates to be evaluated in the human population for its potential in improving the prediction of individual disease risk and the application of personalized therapies.</p>
</sec>
<sec id="s3d">
<title>Cell-type specific gene expression in NAc</title>
<p>While gene interaction is nearly always measured statistically without regard to biological mechanism, we explored the utility of snRNA-seq in identifying cellular and molecular mechanisms of this interaction by examining gene expression in NAc, a brain region relevant to the biological effect of morphine. We focused on NAc because differences in morphine-induced dopamine release in NAc correspond with the locomotor response in the prenatal strains of the BXD mice (<xref ref-type="bibr" rid="c52">Murphy et al., 2001</xref>). Further, mice lacking <italic>Drd1</italic> are not responsive to acute cocaine- (<xref ref-type="bibr" rid="c42">Karlsson et al., 2008</xref>; <xref ref-type="bibr" rid="c75">Xu et al., 1994</xref>) or morphine- (<xref ref-type="bibr" rid="c70">Wang et al., 2015</xref>) induced locomotor response. While our analysis identified 17 distinctive cell types (<xref rid="fig7" ref-type="fig">Figure 7a</xref>), <italic>Oprm1</italic> was detected almost exclusively in the D1-MSN-3 subtype that have high expression of <italic>Foxp2</italic> and low expression of <italic>Ppp1r1b</italic> (i.e. <italic>Darpp-32</italic>; <xref rid="fig7" ref-type="fig">Figure 7b,c</xref>). The total number of genes (n_feature RNA) and other quality control (QC) parameters in D1-MSN-3 are comparable with other neuronal cell types. In contrast, <italic>Fgf12</italic> was expressed in most of the neuronal and glial cell types (<xref rid="fig7" ref-type="fig">Figure 7d</xref>). The expression level of <italic>Oprm1</italic> and <italic>Fgf12</italic> were positively correlated (r = 0.36, p = 6e-8) in D1-MSN-3 but not in D1-MSN-2 cells. MSNs in the NAc have been the subject of intense research. A recent snRNA-seq study of the NAc in rat brains also detected this specific subtype expressing high levels of <italic>Oprm1</italic>, which is selectively labeled by the expression of <italic>Chst9</italic> (<xref ref-type="bibr" rid="c1">Andraka et al., 2023</xref>; <xref ref-type="bibr" rid="c58">Savell et al., 2020</xref>). These data suggest that D1-MSN-3 is a highly likely location for the interaction between <italic>Orpm1</italic> and <italic>Fgf12</italic>. Notably, this cell type is conserved also in primate and human NAc snRNA-seq data (<xref ref-type="bibr" rid="c1">Andraka et al., 2023</xref>), suggesting that it may play a role in opioid responses across species.</p>
<p>To further confirm our results and allow for analysis of correlations, we queried data from the <italic>Ratlas</italic> (<ext-link ext-link-type="uri" xlink:href="https://day-lab.shinyapps.io/ratlas/">https://day-lab.shinyapps.io/ratlas/</ext-link>), which reveals that <italic>Fgf12</italic> is indeed widely expressed in all cell types in other datasets, and that <italic>Oprm1</italic> was not detected in either <italic>Drd1</italic> or <italic>Drd2</italic> MSN neurons. This is most likely due to the lack of detection of the MSN subclass that is equivalent to the D1-MSN-3 subtype that we identified (<xref ref-type="fig" rid="figs6">Supplementary Figure 6a-d</xref>). However, cultured cell data do express <italic>Oprm1</italic> in both <italic>Drd1</italic> and <italic>Drd2</italic> cells (<xref ref-type="fig" rid="figs6">Supplementary Figure 6e-f</xref>). While out of the scope of this paper, future work will be needed to assess the impact of the <italic>Oprm1-Fgf12</italic> interaction on the activity of the D1-MSN-3 population in mediating opioid responses.</p>
</sec>
<sec id="s3e">
<title>Bayesian causal network modeling of <italic>OPRM1</italic> and <italic>FGF12</italic></title>
<p>We included gene expression data of several MAP kinases and sodium channels with known relationships with <italic>Oprm1</italic> and <italic>Fgf12</italic> as the input for our BN. The resulting network (<xref rid="fig8" ref-type="fig">Figure 8</xref>) indicated that <italic>Mapk8ip2</italic>, <italic>Mak3k11</italic> (<italic>Mlk3</italic>), and <italic>Map3k12</italic> (<italic>Dlk</italic>) form a highly interactive network mediating the interaction between <italic>Oprm1</italic> and <italic>Fgf12</italic> in regulating their effects on morphine-induced locomotor response. In addition to validating the results on genetic influence on <italic>Oprm1</italic> and <italic>Fgf12</italic> expression and morphine-induced locomotor response, the network identified <italic>Map3k11</italic> as a potential nexus that links <italic>Oprm1</italic> and <italic>Fgf12. Map3k11</italic> further ddactivates other MAP kinases such as <italic>Mapk8ip2</italic> and <italic>Map3k12</italic> to modulate locomotion before 120 min. Thus, Map3k11 is a potential mediator of the epistasis between <italic>Oprm1</italic> and <italic>Fgf11</italic>. Some of these interactions in the network have been documented, such as those between <italic>Mapk8ip2</italic> and <italic>Mapk11</italic> (<xref ref-type="bibr" rid="c8">Buchsbaum et al., 2002</xref>). Our BN did not contain a direct relationship between <italic>Fgf12</italic> and <italic>Mapk8ip2</italic>, the encoded proteins for which directly bind to each other (<xref ref-type="bibr" rid="c6">Bhushan et al., 2017</xref>). It is possible that these two proteins do not regulate each other’s mRNA levels, which was used in our BN. While our modeling suggested that the epistatic interaction between <italic>Oprm1</italic> and <italic>Fgf12</italic> is potentially mediated through <italic>Map3k11</italic>, further research is needed to fully understand the mechanisms by which <italic>MAPK8IP2</italic>, <italic>MAP3K11</italic>, and <italic>MAP3K12</italic> mediate the interaction of the <italic>FGF12</italic> and <italic>OPRM1</italic> genes, and to determine their precise role in the regulation of these genes.</p>
</sec>
<sec id="s3f">
<title>Genetic modulation of naloxone effects</title>
<p>Naloxone is a potent opioid antagonist that reverses opioid overdoses (<xref ref-type="bibr" rid="c66">Theriot et al., 2022</xref>), and is often used in treatment settings or as a primary overdose prevention method. Pharmacogenomics has primarily focused on individualized treatment for pain, with less priority on OUD. However, understanding the role genetics plays in naloxone’s mechanism could initiate potentially more personalized and effective treatments for OUD. We identified multiple significant associations between behavioral measures of the effect of naloxone on Chrs 3, 5, 7, 10, 11, 12, 13, 14, and 18. These loci are likely to contain novel genes that play a role in OUD, warranting the need for future targeted studies to understand relationships between these genes and their associated phenotypes. For example, <italic>Slc7a7</italic> and <italic>Slc7a8</italic> are candidate genes for the number of jumps after naloxone injection. Both of these genes are a part of the solute carrier family, which play a large role in the absorption of drugs and xenobiotics (<xref ref-type="bibr" rid="c43">Lin et al., 2015</xref>), and are expressed in the brain. Similar to the morphine locomotion time series phenotypes, there are significant QTL for the differences in locomotion before and after naloxone injection (<xref rid="fig8" ref-type="fig">Figure 8c-d</xref>) on Chrs 10 and 16. While the Chr 10 locus slightly missed the genome-wide significance level in females, it nevertheless revealed a very strong trend. Mice with the <italic>B</italic> allele at the <italic>Fgf12</italic> locus still had elevated locomotion during 165-180 min compared to those with the <italic>D</italic> allele. Injection of naloxone eliminated the remaining effect of morphine and brought locomotion in both genotypes close to baseline level (<xref ref-type="fig" rid="figs7">Supplementary Figure 7</xref>). The difference in locomotion before vs after naloxone injection thus amplified the net effect of morphine at this late phase and further confirmed that this effect was mediated via the MOR. The highly significant association (-log<sub>10</sub>P = 5.34 in males and -log<sub>10</sub>P = 9.57 in females) between the Chr 16 locus and this phenotype provided a strong confirmation for its role in late phase response to morphine. Analysis of these genes in the homologous human regions in larger populations are needed to translationally confirm and extend the validity of these results.</p>
</sec>
<sec id="s3g">
<title>Integration with human data</title>
<p>While our attempt to integrate murine data with human GWAS results demonstrated that the pipeline works, the lack of enrichment for the network in OUD GWAS could likely be due to the small sample size in the original human data for that specific SUD. This could also likely be due to the lack of data specification, such as the differences between examining physical dependence vs the development of OUD, initial use vs problematic use, and withdrawal vs relapse (<xref ref-type="bibr" rid="c57">Sanchez-Roige et al., 2021</xref>). All these specifics across OUD stages also come with continually evolving definitions, and, therefore, also contributes to uncertainty and potential loss of significant results.</p>
<p>In summary, our study confirmed that the <italic>Oprm1</italic> locus strongly modulates the early phase locomotor response to morphine and identified a novel association between <italic>Fgf12</italic> locus and the late phase response to morphine. To the best of our knowledge, the epistatic interaction between the <italic>Oprm1</italic> and <italic>Fgf12</italic> loci during the middle phase of locomotor response is the first demonstration of a transient time-dependent epistatic interaction modulating drug response in mammals—a finding with interesting mechanistic implications. Our snRNA-seq analysis suggests that the D1-MSN-3 subpopulation of dopaminergic-receptor neurons might be critical in the epistatic interaction between <italic>Oprm1</italic> and <italic>Fgf12</italic>. Our study further shows that the interaction between the <italic>Fgf12</italic> and <italic>Oprm1</italic> genes is mediated by <italic>Mapk8ip2, Map3k11</italic>, and <italic>Map3k12</italic>, and that the activity of these proteins is modulated by the presence of <italic>Fgf12</italic> variants. Finally, this work demonstrates how high-quality Findabile, Accessible, Interoperabile, and Reusable (FAIR+) phenotypes can be used with updated data sets to yield striking results, and how joint mouse and human neurogenomic and GWAS results can be merged at gene and network levels for bidirectional validation of SUD variants and molecular networks.</p>
</sec>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Animal and Behavior Data Collection</title>
<p>Morphine-induced locomotor responses and naloxone-induced withdrawal were recorded for 64 BXD RI strains. All animals were young adults (8–9 weeks) reared at the Oak Ridge National Laboratory in 2007–2008. Detailed methods were reported in the original publication by <xref ref-type="bibr" rid="c55">Philip et al (2010)</xref>. Briefly, the testing protocols included giving each mouse a single i.p. injection of morphine sulfate (50 mg/kg in isotonic saline at a volume of 10 ml/kg), followed by immediately placing the mice into an activity chamber (43.2 cm L × 43.2 cm W × 30.4 cm H, ENV-515, Med Associates, St Albans, VT, USA). Each chamber contained two sets of 16 photocells placed at 2.5 and 5 cm above the chamber floor. Activity was measured as photocell beam breaks and converted into horizontal distance traveled (cm). This behavior and rearing were recorded for 3 h and were exported as the sum of 15 min bins. Then, each mice in these cases received an injection of naloxone (30 mg/kg in isotonic saline at a volume of 10 ml/kg, i.p.), and were immediately returned to the chambers for an additional 15 minutes. Naloxone’s effects on locomotor activity levels, and signs of withdrawal were recorded for 15 minutes, including the number of jumps, fecal boli, urine puddles, wet dog shakes, instances of abdominal contraction, salivation, ptosis and abnormal posture were recorded for 15 minutes). The number of animals used per strain was 7.8 (mean ± SD) for females and 6.6 for males. Testing occurred at about 8 to 9 weeks after birth.</p>
</sec>
<sec id="s4b">
<title>QTL Mapping in GeneNetwork</title>
<p>We reanalyzed 105 phenotypes from the <xref ref-type="bibr" rid="c55">Philip et al. (2010)</xref> study available in <ext-link ext-link-type="uri" xlink:href="https://GeneNetwork.org">GeneNetwork.org</ext-link>, a database containing phenotypes and genotypes, and also serves as an analysis engine for quantitative trait locus (QTL) mapping, genetic correlations, and phenome-wide association studies (<xref ref-type="bibr" rid="c51">Mulligan et al., 2017</xref>; <xref ref-type="bibr" rid="c62">Sloan et al., 2016</xref>; <xref ref-type="bibr" rid="c71">Watson and Ashbrook, 2020</xref>). The trait IDs and their most significant loci are shown in <xref ref-type="table" rid="tbls2">Supplementary Table 2</xref>. The data for mapping QTLs consist of polymorphic genetic markers and quantitative trait values for strain means. Statistical heritability was also evaluated to estimate the degree of variation among the morphine and naloxone traits due to genetic variation. The original analysis (<xref ref-type="bibr" rid="c55">Philip et al., 2010</xref>) was performed with the expanded BXD strain to evaluate complementary behavioral phenotyping using Haley-Knott regression in GeneNetwork. In our reanalysis, we first quantile normalized the trait data. We then used the newly implemented GEMMA algorithm with the LOCO option, which corrects family structure, to perform genetic mapping. Candidate genes were selected from the confidence interval of a one-LOD drop-off from the peak statistical significance as determined previously (<xref ref-type="bibr" rid="c55">Philip et al., 2010</xref>). The criterion for genome-wide significance was a –log<sub>10</sub>P value of 3.77 for the BXDs. Loci labeled by genetic markers could act independently at all time points or possibly in an epistatic interaction at a few time points. Therefore, we also examined epistatic interactions between two loci by performing a pair-scan, implemented in GeneNetwork (v1). This scan generated a matrix map output. Functional enrichment of these networks were obtained using WebGestalt (<xref ref-type="bibr" rid="c77">Zhang et al., 2005</xref>). The biological relevance of candidate genes in the context of SUD was queried using Genecup (<xref ref-type="bibr" rid="c36">Gunturkun et al., 2022</xref>). We conducted most early exploratory analysis using the web version of Genenetwork. For final analysis, we used the API interface of genenetwork (<xref ref-type="bibr" rid="c51">Mulligan et al., 2017</xref>) to conduct standardized analysis and generate uniform figures for all phenotypes of interest.</p>
</sec>
<sec id="s4c">
<title>Brain samples for snRNA-seq</title>
<p>Brain samples from 2 female HS rats were obtained from the oxycodone tissue repository at UCSD (<xref ref-type="bibr" rid="c12">Carrette et al., 2021</xref>). The brain tissues were collected from rats sacrificed after 4 weeks of prolonged abstinence from oxycodone intravenous self-administration. The rats used in this study displayed a low addiction index-like behavior, which is calculated using several behavioral measures, as detailed in Carrette et al, (<xref ref-type="bibr" rid="c12">Carrette et al., 2021</xref>). Brain tissue was extracted and snap-frozen (at −30°C). Cryosections of ∼500 microns (Bregma 2.28-0.72 mm) were used to dissect the NAc core punches on a −20°C frozen stage. Punches from 3 sections were combined for each rat.</p>
</sec>
<sec id="s4d">
<title>snRNA-seq library preparations</title>
<p>snRNA-seq library was performed using the Chromium Next GEM Single Cell Multiome Reagent Kit A (catalog number 1000282) following Chromium Next GEM Single Cell Multiome ATAC + Gene Expression Reagent Kits User Guide (10X Genomics). Approximately 10,000 nuclei were loaded per reaction, targeting recovery of 6,000 nuclei after encapsulation. After the transposition reaction, nuclei were encapsulated and barcoded. Next-generation sequencing libraries were constructed following the User Guide. Final library concentration was assessed by Qubit dsDNA HS Assay Kit (Thermo-Fischer Scientific) and post library QC was performed using Tapestation High Sensitivity D1000 (Agilent) to ensure that fragment sizes were distributed as expected. Final libraries were sequenced using the NovaSeq6000 (Illumina).</p>
</sec>
<sec id="s4e">
<title>Bioinformatic analysis of snRNA-seq data</title>
<p>Raw sequencing data were converted to FASTQ format using bcl2fastq (Illumina). The FASTQ data were firstly aligned to the Rattus Norvegicus mRatBN7.2/rn7 genome and then aggregated into one sample file using CellRanger version 2.0.0 using default parameters. The output files were analyzed using Seurat version 4.1.1 (<xref ref-type="bibr" rid="c65">Stuart et al., 2019</xref>). Nuclei with gene numbers between 500 and 6000, RNA counts between 1000 and 16000, the percentage of mitochondrial gene reads lower than 2%, and the percentage of small 40S or large 60S ribosomal (Rps and Rpl) gene reads lower than 1% were considered as high-quality cells and kept for further analyses. To eliminate potential doublets, we used DoubletFinder 2.0.3 and removed 5% nuclei identified as doublets (<xref ref-type="bibr" rid="c48">McGinnis et al., 2019</xref>).</p>
<p>High-quality singlet nuclei were then normalized and scaled using SCT transformation (<xref ref-type="bibr" rid="c37">Hafemeister and Satija, 2019</xref>) with the percentage of mitochondrial genes, RNA counts, and sample ID as covariates. The dimensional reduction was performed using PCA and the first 30 PCs were used for KNN graph construction and clustering using the Louvain algorithm. Uniform manifold approximation and projection (UMAP) was used for visualization of the clusters. The dot plots and violin plots were generated using Seurat (<xref ref-type="bibr" rid="c65">Stuart et al., 2019</xref>). Pearson correlation was computed in R 4.2.1 using cor.test and p&lt;0.05 was considered significant.</p>
</sec>
<sec id="s4f">
<title>Human translational data</title>
<p>First, we reviewed OUD and other relevant published GWAS data in previous literature with variants in <italic>OPRM1</italic> and <italic>FGF12</italic>. We also extended our review to looking at potential roles of <italic>FGF12</italic> in humans specifically. Then, All the files for <italic>FGF12</italic> and <italic>OPRM1</italic> correlations for each individual brain region as well as some controls were downloaded using GTEx v8 (<xref ref-type="bibr" rid="c35">GTEx Consortium et al., 2017</xref>) and GeneNetwork and then extracted out the shared genes with a liberal cut-off of 500 genes. We ran a genome-wide enrichment analysis using MAGMA, a powerful tool that identifies genes and gene-sets associated with a specific disease for analysis (<xref ref-type="bibr" rid="c21">de Leeuw et al., 2015</xref>). However, upon running our genome-wide enrichment analysis for OUD, we realized our initial search was too broad and much larger than in previous literature (see results section). To reduce the amount of noise we identified genes that overlap between <italic>FGF12</italic> and <italic>OPRM1</italic> in a given tissue, and identified genes correlated specifically to each <italic>OPRM1</italic> and <italic>FGF12</italic> in several tissues. To do this we developed a list of genes (and Ensembl IDs) in each brain region to examine the number of occurrences each gene is seen across this data. We narrowed down our search to the top genes with high counts and compared them to the same number of genes with a count of only one. The count is the number of times the gene is associated with both <italic>FGF12</italic> and <italic>OPRM1</italic> in all the regions/tissue datasets in GeneNetwork. Association is defined as among the top 500 genes ranked by correlation with <italic>FGF12</italic> or <italic>OPRM1</italic>.</p>
</sec>
<sec id="s4g">
<title>Bayesian network modeling</title>
<p>The BN server located at <ext-link ext-link-type="uri" xlink:href="https://bnw.genenetwork.org/sourcecodes/home.php">https://bnw.genenetwork.org/sourcecodes/home.php</ext-link> was used. Raw data files containing genotypes for the <italic>Oprm1</italic> and <italic>Fgf12</italic> loci, morphine-induced locomotion, and expression levels of relevant genes (sodium channels, MAP kinases) were transferred from Genentwork. We separated our nodes into 4 tiers to label chromosome location, candidate gene, signaling molecules, and phenotype (morphine locomotion) each as a separate tier. These are used to organize the nodes into different layers. Each tier represents a different layer of complexity. We permitted causal connections to flow from the first tier to the second tier, as well as from the second tier to the third tier. We also allowed interaction between nodes located within the second or the third tiers.</p>
</sec>
<sec id="s4h" sec-type="data-availability">
<title>Data availability</title>
<p>snRNA-seq data has been deposited into NCBI GEO (accession number: GSE214388).</p>
</sec>
</sec>
</body>
<back>
<sec id="sec27" sec-type="supplementary">
<title>Supplementary Figures and Tables</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 1:</label>
<caption><title>Distribution of raw locomotion data after morphine injection.</title>
<p>Distribution of raw data for locomotion after morphine injection at different time intervals in females (orange <bold>A-K</bold>) and males (blue <bold>L-V</bold>). Data for 135 to 150 minutes were lost for both sexes.</p></caption>
<graphic xlink:href="483993v3_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 2:</label>
<caption><title>Distribution of quantile-normalized locomotion data after morphine injection.</title>
<p>Data are plotted for each time bin for both females (orange <bold>A-K</bold>) and males (blue <bold>L-V</bold>). Data for 135 to 150 minutes were lost for both sexes.</p></caption>
<graphic xlink:href="483993v3_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 3:</label>
<caption><title>Pairwise linkage statistics across the genome.</title>
<p><bold>(a)</bold> Genome-wide two-dimensional heat map showing all pairwise marker combinations, illustrating both additive (main) effects and epistatic (interaction) effects. The upper-left triangle displays LOD scores for interaction terms, while the rightmost column shows the main effect (single-locus) genome scan. <bold>(b)</bold> Zoomed view of linkage statistics between chromosomes 10 and 16. The red band along the bottom represents a strong additive effect on chromosome 16.</p></caption>
<graphic xlink:href="483993v3_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 4:</label>
<caption><title>Quality control (QC) of snRNA-seq and number of cells per cluster.</title>
<p><bold>(a-e)</bold> Violin plots showing QC parameters used for selecting high-quality nuclei in each sample: <bold>(a)</bold> Unique gene numbers per nuclei (nFeature_RNA). <bold>(b)</bold> Log-transformed total read numbers per nuclei (log-nCount_RNA). <bold>(c)</bold> Percentage of mitochondrial gene reads. <bold>(d)</bold> Percentage of small 40s ribosomal (Rps) gene reads. <bold>(e)</bold> Percentage of large 60s ribosomal (Rpl) gene reads. <bold>(f)</bold> Number of nuclei per cell cluster. D1-MSN, Drd1-expressing medium spiny neuron; D2-MSN, Drd2-expressing medium spiny neuron; GABA, GABAergic inhibitory neuron; Glut, glutamatergic excitatory neuron; Ol, oligodendrocyte; OPC, oligodendrocyte precursor cell; Ast, astrocyte, Mg, microglial cells.</p></caption>
<graphic xlink:href="483993v3_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 5:</label>
<caption><title>Levels of <italic>Oprm1</italic>, <italic>Fgf12</italic>, and MAP kinases proteins in the brains of BXD parental strains and F1s.</title>
<p>Effect of genotype on associated MAP kinases and genes for both parental strains and F1 generations. The genotype effect shows the <italic>B</italic> allele is associated with high expression of <italic>Oprm1</italic> and the MAP kinases <italic>Mapk8ip2</italic>, <italic>Map3k11</italic>, and <italic>Map3k12</italic>, but low expression of <italic>Fgf12</italic>, when compared to the <italic>D</italic> allele.</p></caption>
<graphic xlink:href="483993v3_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs6" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 6:</label>
<caption><title>Gene Expression of D1 and D2 Type Medium Spiny Neuron Subtypes.</title>
<p>Expression of <italic>Oprm1</italic> and <italic>Fgf12</italic> in acute and repeated nucleus accumbens and in primary striatal culture from the Ratlas database. <bold>(a)</bold> Expression of <italic>Oprm1</italic> in acute NAc. <bold>(b)</bold> Expression of <italic>Fgf12</italic> in acute NAc. <bold>(c)</bold> Expression of <italic>Oprm1</italic> in both acute and repeated NAc. <bold>(d)</bold> Expression of <italic>Fgf12</italic> in both acute and repeated NAc. <bold>(e)</bold> Expression of <italic>Oprm1</italic> in primary striatal culture. <bold>(f)</bold> Expression of <italic>Fgf12</italic> in primary striatal culture.</p></caption>
<graphic xlink:href="483993v3_figs6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<table-wrap id="tbls1" orientation="portrait" position="float">
<label>Supplementary Table 1.</label>
<caption><title>Genome-wide significant loci associated with morphine and naloxone responses (quantile-normalized).</title></caption>
<graphic xlink:href="483993v3_tbls1.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="483993v3_tbls1a.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="483993v3_tbls1b.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="483993v3_tbls1c.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<table-wrap id="tbls2" orientation="portrait" position="float">
<label>Supplementary Table 2.</label>
<caption><title>List of Locomotion Trait IDs.</title></caption>
<graphic xlink:href="483993v3_tbls2.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="483993v3_tbls2a.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<fig id="figs7" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 7:</label>
<caption><title>Naloxone Phenotypes vs. Genotypes.</title>
<p>The turquoise points show morphine-induced locomotion (distance traveled in cm) between 165–180 min after injection. Orange points show the change in locomotion measured by the last 15 min of morphine locomotion response minus the first 15 min after naloxone injection. <bold>(a)</bold> Effect of genotype on two naloxone phenotypes in males. <bold>(b)</bold> Effect of genotype on number of beam breaks in an open field 0–15 min after naloxone injection in males. <bold>(c)</bold> Effect of genotype on two naloxone phenotypes in females. <bold>(d)</bold> Effect of genotype on the number of beam breaks in an open field 0–15 min after naloxone injection in females.</p></caption>
<graphic xlink:href="483993v3_figs7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Andraka</surname> <given-names>E</given-names></string-name>, <string-name><surname>Phillips</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Brida</surname> <given-names>KL</given-names></string-name>, <string-name><surname>Day</surname> <given-names>JJ.</given-names></string-name></person-group> <year>2023</year>. <article-title>Chst9 Marks a Spatially and Transcriptionally Unique Population of Oprm1 -Expressing Neurons in the Nucleus Accumbens</article-title>. <source>bioRxiv</source>. doi:<pub-id pub-id-type="doi">10.1101/2023.10.16.562623</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ashbrook</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Arends</surname> <given-names>D</given-names></string-name>, <string-name><surname>Prins</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mulligan</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Roy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Lutz</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Valenzuela</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bohl</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Ingels</surname> <given-names>JF</given-names></string-name>, <string-name><surname>McCarty</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Centeno</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Hager</surname> <given-names>R</given-names></string-name>, <string-name><surname>Auwerx</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>RW</given-names></string-name></person-group>. <year>2021</year>. <article-title>A platform for experimental precision medicine: The extended BXD mouse family</article-title>. <source>Cell Syst</source> <volume>12</volume>:<fpage>235</fpage>–<lpage>247.</lpage> </mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ballester</surname> <given-names>J</given-names></string-name>, <string-name><surname>Baker</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Martikainen</surname> <given-names>IK</given-names></string-name>, <string-name><surname>Koppelmans</surname> <given-names>V</given-names></string-name>, <string-name><surname>Zubieta</surname> <given-names>J-K</given-names></string-name>, <string-name><surname>Love</surname> <given-names>TM</given-names></string-name></person-group>. <year>2022</year>. <article-title>Risk for opioid misuse in chronic pain patients is associated with endogenous opioid system dysregulation</article-title>. <source>Transl Psychiatry</source> <volume>12</volume>:<fpage>20</fpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bergeson</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Helms</surname> <given-names>ML</given-names></string-name>, <string-name><surname>O’Toole</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Jarvis</surname> <given-names>MW</given-names></string-name>, <string-name><surname>Hain</surname> <given-names>HS</given-names></string-name>, <string-name><surname>Mogil</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Belknap</surname> <given-names>JK</given-names></string-name></person-group>. <year>2001</year>. <article-title>Quantitative trait loci influencing morphine antinociception in four mapping populations</article-title>. <source>Mamm Genome</source> <volume>12</volume>:<fpage>546</fpage>–<lpage>553</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berrettini</surname> <given-names>W</given-names></string-name></person-group>. <year>2017</year>. <article-title>A brief review of the genetics and pharmacogenetics of opioid use disorders</article-title>. <source>Dialogues Clin Neurosci</source> <volume>19</volume>:<fpage>229</fpage>–<lpage>236</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhushan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kapur</surname> <given-names>S</given-names></string-name>, <string-name><surname>Borthakar</surname> <given-names>BB</given-names></string-name>, <string-name><surname>Sharma</surname> <given-names>J</given-names></string-name>, <string-name><surname>Rai</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Kataki</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Saxena</surname> <given-names>S.</given-names></string-name></person-group> <year>2017</year>. <article-title>Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets</article-title>. <source>Omics</source> <volume>21</volume>:<fpage>616</fpage>–<lpage>631</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blackwood</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Leary</surname> <given-names>M</given-names></string-name>, <string-name><surname>Salisbury</surname> <given-names>A</given-names></string-name>, <string-name><surname>McCoy</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Cadet</surname> <given-names>JL</given-names></string-name></person-group>. <year>2019</year>. <article-title>Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving</article-title>. <source>Neuroscience</source> <volume>415</volume>:<fpage>173</fpage>–<lpage>183</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Buchsbaum</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Connolly</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Feig</surname> <given-names>LA</given-names></string-name></person-group>. <year>2002</year>. <article-title>Interaction of Rac exchange factors Tiam1 and Ras-GRF1 with a scaffold for the p38 mitogen-activated protein kinase cascade</article-title>. <source>Mol Cell Biol</source> <volume>22</volume>:<fpage>4073</fpage>–<lpage>4085</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Byrne</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Gehrman</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Medland</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Nyholt</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Heath</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Madden</surname> <given-names>PAF</given-names></string-name>, <string-name><surname>Hickie</surname> <given-names>IB</given-names></string-name>, <string-name><surname>Van Duijn</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Henders</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Montgomery</surname> <given-names>GW</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Wray</surname> <given-names>NR</given-names></string-name>, <collab>Chronogen Consortium</collab></person-group>. <year>2013</year>. <article-title>A genome-wide association study of sleep habits and insomnia</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source> <volume>162B</volume>:<fpage>439</fpage>–<lpage>451</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Campbell</surname> <given-names>RF</given-names></string-name>, <string-name><surname>McGrath</surname> <given-names>PT</given-names></string-name>, <string-name><surname>Paaby</surname> <given-names>AB</given-names></string-name></person-group>. <year>2018</year>. <article-title>Analysis of Epistasis in Natural Traits Using Model Organisms</article-title>. <source>Trends Genet</source> <volume>34</volume>:<fpage>883</fpage>–<lpage>898</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carlborg</surname> <given-names>O</given-names></string-name>, <string-name><surname>Haley</surname> <given-names>CS</given-names></string-name></person-group>. <year>2004</year>. <article-title>Epistasis: too often neglected in complex trait studies?</article-title> <source>Nat Rev Genet</source> <volume>5</volume>:<fpage>618</fpage>–<lpage>625</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carrette</surname> <given-names>LLG</given-names></string-name>, <string-name><surname>de Guglielmo</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kallupi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Maturin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Brennan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Boomhower</surname> <given-names>B</given-names></string-name>, <string-name><surname>Conlisk</surname> <given-names>D</given-names></string-name>, <string-name><surname>Sedighim</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tieu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Fannon</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Velarde</surname> <given-names>N</given-names></string-name>, <string-name><surname>Martinez</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Kononoff</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kimbrough</surname> <given-names>A</given-names></string-name>, <string-name><surname>Simpson</surname> <given-names>S</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>LC</given-names></string-name>, <string-name><surname>Shankar</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ramirez</surname> <given-names>FJ</given-names></string-name>, <string-name><surname>Chitre</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>B</given-names></string-name>, <string-name><surname>Polesskaya</surname> <given-names>O</given-names></string-name>, <string-name><surname>Solberg Woods</surname> <given-names>LC</given-names></string-name>, <string-name><surname>Palmer</surname> <given-names>AA</given-names></string-name>, <string-name><surname>George</surname> <given-names>O.</given-names></string-name></person-group> <year>2021</year>. <article-title>The Cocaine and Oxycodone Biobanks, Two Repositories from Genetically Diverse and Behaviorally Characterized Rats for the Study of Addiction</article-title>. <source>eNeuro</source> <volume>8</volume>. doi:<pub-id pub-id-type="doi">10.1523/ENEURO.0033-21.2021</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>H</given-names></string-name>, <string-name><surname>Sherva</surname> <given-names>R</given-names></string-name>, <string-name><surname>Farrer</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Kranzler</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name></person-group>. <year>2018</year>. <article-title>Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans</article-title>. <source>Biol Psychiatry</source>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.12.016</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chicco</surname> <given-names>D</given-names></string-name>, <string-name><surname>Faultless</surname> <given-names>T</given-names></string-name></person-group>. <year>2021</year>. <article-title>Brief Survey on Machine Learning in Epistasis</article-title>. <source>Methods Mol Biol</source> <volume>2212</volume>:<fpage>169</fpage>–<lpage>179</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Contet</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kieffer</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Befort</surname> <given-names>K</given-names></string-name></person-group>. <year>2004</year>. <article-title>Mu opioid receptor: a gateway to drug addiction</article-title>. <source>Curr Opin Neurobiol</source> <volume>14</volume>:<fpage>370</fpage>–<lpage>378</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cox</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Sherva</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Lunetta</surname> <given-names>KL</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Degenhardt</surname> <given-names>L</given-names></string-name>, <string-name><surname>Agrawal</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Kranzler</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name>, <string-name><surname>Farrer</surname> <given-names>LA</given-names></string-name></person-group>. <year>2020</year>. <article-title>Genome-Wide Association Study of Opioid Cessation</article-title>. <source>J Clin Med Res</source> <volume>9</volume>. doi:<pub-id pub-id-type="doi">10.3390/jcm9010180</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crist</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Reiner</surname> <given-names>BC</given-names></string-name>, <string-name><surname>Berrettini</surname> <given-names>WH</given-names></string-name></person-group>. <year>2019</year>. <article-title>A review of opioid addiction genetics</article-title>. <source>Curr Opin Psychol</source> <volume>27</volume>:<fpage>31</fpage>–<lpage>35</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crocco</surname> <given-names>P</given-names></string-name>, <string-name><surname>Dato</surname> <given-names>S</given-names></string-name>, <string-name><surname>La Grotta</surname> <given-names>R</given-names></string-name>, <string-name><surname>Passarino</surname> <given-names>G</given-names></string-name>, <string-name><surname>Rose</surname> <given-names>G.</given-names></string-name></person-group> <year>2024</year>. <article-title>Evidence for a relationship between genetic polymorphisms of the L-DOPA transporter LAT2/4F2hc and risk of hypertension in the context of chronic kidney disease</article-title>. <source>BMC Med Genomics</source> <volume>17</volume>:<fpage>163</fpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cui</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ostlund</surname> <given-names>SB</given-names></string-name>, <string-name><surname>James</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Park</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Ge</surname> <given-names>W</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>KW</given-names></string-name>, <string-name><surname>Mittal</surname> <given-names>N</given-names></string-name>, <string-name><surname>Murphy</surname> <given-names>NP</given-names></string-name>, <string-name><surname>Cepeda</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kieffer</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Levine</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Jentsch</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Walwyn</surname> <given-names>WM</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>YE</given-names></string-name>, <string-name><surname>Evans</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Maidment</surname> <given-names>NT</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>XW</given-names></string-name></person-group>. <year>2014</year>. <article-title>Targeted expression of μ-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward</article-title>. <source>Nat Neurosci</source> <volume>17</volume>:<fpage>254</fpage>–<lpage>261</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deak</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>H</given-names></string-name>, <string-name><surname>Galimberti</surname> <given-names>M</given-names></string-name>, <string-name><surname>Levey</surname> <given-names>DF</given-names></string-name>, <string-name><surname>Wendt</surname> <given-names>FR</given-names></string-name>, <string-name><surname>Sanchez-Roige</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hatoum</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Nunez</surname> <given-names>YZ</given-names></string-name>, <string-name><surname>Demontis</surname> <given-names>D</given-names></string-name>, <string-name><surname>Børglum</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Rajagopal</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Jennings</surname> <given-names>MV</given-names></string-name>, <string-name><surname>Kember</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Justice</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Edenberg</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Agrawal</surname> <given-names>A</given-names></string-name>, <string-name><surname>Polimanti</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kranzler</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name></person-group>. <year>2022</year>. <article-title>Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci</article-title>. <source>Mol Psychiatry</source> <volume>27</volume>:<fpage>3970</fpage>–<lpage>3979</lpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Leeuw</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Mooij</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Heskes</surname> <given-names>T</given-names></string-name>, <string-name><surname>Posthuma</surname> <given-names>D</given-names></string-name></person-group>. <year>2015</year>. <article-title>MAGMA: generalized gene-set analysis of GWAS data</article-title>. <source>PLoS Comput Biol</source> <volume>11</volume>:<fpage>e1004219</fpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Vries</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Shippenberg</surname> <given-names>TS.</given-names></string-name></person-group> <year>2002</year>. <article-title>Neural systems underlying opiate addiction</article-title>. <source>J Neurosci</source> <volume>22</volume>:<fpage>3321</fpage>–<lpage>3325</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>D’Silva</surname> <given-names>S</given-names></string-name>, <string-name><surname>Chakraborty</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kahali</surname> <given-names>B</given-names></string-name></person-group>. <year>2022</year>. <article-title>Concurrent outcomes from multiple approaches of epistasis analysis for human body mass index associated loci provide insights into obesity biology</article-title>. <source>Sci Rep</source> <volume>12</volume>:<fpage>7306</fpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Evans</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Choudary</surname> <given-names>PV</given-names></string-name>, <string-name><surname>Neal</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Li</surname> <given-names>JZ</given-names></string-name>, <string-name><surname>Vawter</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Tomita</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lopez</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Thompson</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Meng</surname> <given-names>F</given-names></string-name>, <string-name><surname>Stead</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Walsh</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Myers</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Bunney</surname> <given-names>WE</given-names></string-name>, <string-name><surname>Watson</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Jones</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Akil</surname> <given-names>H.</given-names></string-name></person-group> <year>2004</year>. <article-title>Dysregulation of the fibroblast growth factor system in major depression</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>101</volume>:<fpage>15506</fpage>–<lpage>15511</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Even-Chen</surname> <given-names>O</given-names></string-name>, <string-name><surname>Barak</surname> <given-names>S</given-names></string-name></person-group>. <year>2019a</year>. <article-title>The role of fibroblast growth factor 2 in drug addiction</article-title>. <source>Eur J Neurosci</source> <volume>50</volume>:<fpage>2552</fpage>–<lpage>2561</lpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Even-Chen</surname> <given-names>O</given-names></string-name>, <string-name><surname>Barak</surname> <given-names>S</given-names></string-name></person-group>. <year>2019b</year>. <article-title>Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum</article-title>. <source>J Neurosci</source> <volume>39</volume>:<fpage>7947</fpage>–<lpage>7957</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Even-Chen</surname> <given-names>O</given-names></string-name>, <string-name><surname>Sadot-Sogrin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Shaham</surname> <given-names>O</given-names></string-name>, <string-name><surname>Barak</surname> <given-names>S</given-names></string-name></person-group>. <year>2017</year>. <article-title>Fibroblast Growth Factor 2 in the Dorsomedial Striatum Is a Novel Positive Regulator of Alcohol Consumption</article-title>. <source>J Neurosci</source> <volume>37</volume>:<fpage>8742</fpage>–<lpage>8754</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flippo</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Trammell</surname> <given-names>SAJ</given-names></string-name>, <string-name><surname>Gillum</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Aklan</surname> <given-names>I</given-names></string-name>, <string-name><surname>Perez</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Yavuz</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>NK</given-names></string-name>, <string-name><surname>Jensen-Cody</surname> <given-names>SO</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>B</given-names></string-name>, <string-name><surname>Claflin</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Beierschmitt</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fink-Jensen</surname> <given-names>A</given-names></string-name>, <string-name><surname>Knop</surname> <given-names>FK</given-names></string-name>, <string-name><surname>Palmour</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Grueter</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Atasoy</surname> <given-names>D</given-names></string-name>, <string-name><surname>Potthoff</surname> <given-names>MJ</given-names></string-name></person-group>. <year>2022</year>. <article-title>FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit</article-title>. <source>Cell Metab</source> <volume>34</volume>:<fpage>317</fpage>–<lpage>328.</lpage> </mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flores</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Galan-Rodriguez</surname> <given-names>B</given-names></string-name>, <string-name><surname>Rojo</surname> <given-names>AI</given-names></string-name>, <string-name><surname>Ramiro-Fuentes</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cuadrado</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fernandez-Espejo</surname> <given-names>E</given-names></string-name></person-group>. <year>2010</year>. <article-title>Fibroblast growth factor-1 within the ventral tegmental area participates in motor sensitizing effects of morphine</article-title>. <source>Neuroscience</source> <volume>165</volume>:<fpage>198</fpage>–<lpage>211</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gaddis</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mathur</surname> <given-names>R</given-names></string-name>, <string-name><surname>Marks</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>L</given-names></string-name>, <string-name><surname>Quach</surname> <given-names>B</given-names></string-name>, <string-name><surname>Waldrop</surname> <given-names>A</given-names></string-name>, <string-name><surname>Levran</surname> <given-names>O</given-names></string-name>, <string-name><surname>Agrawal</surname> <given-names>A</given-names></string-name>, <string-name><surname>Randesi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Adelson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jeffries</surname> <given-names>PW</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Degenhardt</surname> <given-names>L</given-names></string-name>, <string-name><surname>Montgomery</surname> <given-names>GW</given-names></string-name>, <string-name><surname>Wetherill</surname> <given-names>L</given-names></string-name>, <string-name><surname>Lai</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bucholz</surname> <given-names>K</given-names></string-name>, <string-name><surname>Foroud</surname> <given-names>T</given-names></string-name>, <string-name><surname>Porjesz</surname> <given-names>B</given-names></string-name>, <string-name><surname>Runarsdottir</surname> <given-names>V</given-names></string-name>, <string-name><surname>Tyrfingsson</surname> <given-names>T</given-names></string-name>, <string-name><surname>Einarsson</surname> <given-names>G</given-names></string-name>, <string-name><surname>Gudbjartsson</surname> <given-names>DF</given-names></string-name>, <string-name><surname>Webb</surname> <given-names>BT</given-names></string-name>, <string-name><surname>Crist</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Kranzler</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Sherva</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hulse</surname> <given-names>G</given-names></string-name>, <string-name><surname>Wildenauer</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kelty</surname> <given-names>E</given-names></string-name>, <string-name><surname>Attia</surname> <given-names>J</given-names></string-name>, <string-name><surname>Holliday</surname> <given-names>EG</given-names></string-name>, <string-name><surname>McEvoy</surname> <given-names>M</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Schwab</surname> <given-names>SG</given-names></string-name>, <string-name><surname>Maher</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Gruza</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kreek</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Thorgeirsson</surname> <given-names>T</given-names></string-name>, <string-name><surname>Stefansson</surname> <given-names>K</given-names></string-name>, <string-name><surname>Berrettini</surname> <given-names>WH</given-names></string-name>, <string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name>, <string-name><surname>Edenberg</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Bierut</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hancock</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>EO</given-names></string-name></person-group>. <year>2022</year>. <article-title>Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond</article-title>. <source>Sci Rep</source> <volume>12</volume>:<fpage>16873</fpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kranzler</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Sherva</surname> <given-names>R</given-names></string-name>, <string-name><surname>Koesterer</surname> <given-names>R</given-names></string-name>, <string-name><surname>Almasy</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>H</given-names></string-name>, <string-name><surname>Farrer</surname> <given-names>LA</given-names></string-name></person-group>. <year>2014</year>. <article-title>Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways</article-title>. <source>Biol Psychiatry</source> <volume>76</volume>:<fpage>66</fpage>–<lpage>74</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>GENDEP Investigators</collab>, <collab>MARS Investigators</collab>, <collab>STAR*D Investigators</collab></person-group>. <year>2013</year>. <article-title>Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies</article-title>. <source>Am J Psychiatry</source> <volume>170</volume>:<fpage>207</fpage>–<lpage>217</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldfarb</surname> <given-names>M</given-names></string-name>, <string-name><surname>Schoorlemmer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>A</given-names></string-name>, <string-name><surname>Diwakar</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Giza</surname> <given-names>J</given-names></string-name>, <string-name><surname>Tchetchik</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kelley</surname> <given-names>K</given-names></string-name>, <string-name><surname>Vega</surname> <given-names>A</given-names></string-name>, <string-name><surname>Matthews</surname> <given-names>G</given-names></string-name>, <string-name><surname>Rossi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Ornitz</surname> <given-names>DM</given-names></string-name>, <string-name><surname>D’Angelo</surname> <given-names>E</given-names></string-name></person-group>. <year>2007</year>. <article-title>Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels</article-title>. <source>Neuron</source> <volume>55</volume>:<fpage>449</fpage>–<lpage>463</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>GTEx Consortium</collab></person-group>. <year>2013</year>. <article-title>The Genotype-Tissue Expression (GTEx) project</article-title>. <source>Nat Genet</source> <volume>45</volume>:<fpage>580</fpage>–<lpage>585</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>GTEx Consortium</collab></person-group>. <year>2017</year>. <article-title>Genetic effects on gene expression across human tissues</article-title>. <source>Nature</source> <volume>550</volume>:<fpage>204</fpage>–<lpage>213</lpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gunturkun</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Flashner</surname> <given-names>E</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mulligan</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>RW</given-names></string-name>, <string-name><surname>Prins</surname> <given-names>P</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>H</given-names></string-name></person-group>. <year>2022</year>. <article-title>GeneCup: mining PubMed and GWAS catalog for gene-keyword relationships</article-title>. <source>G3</source>. doi:<pub-id pub-id-type="doi">10.1093/g3journal/jkac059</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hafemeister</surname> <given-names>C</given-names></string-name>, <string-name><surname>Satija</surname> <given-names>R</given-names></string-name></person-group>. <year>2019</year>. <article-title>Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression</article-title>. <source>Genome Biol</source> <volume>20</volume>:<fpage>296</fpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Hatoum</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Colbert</surname> <given-names>SMC</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Huggett</surname> <given-names>SB</given-names></string-name>, <string-name><surname>Deak</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Pathak</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Jennings</surname> <given-names>MV</given-names></string-name>, <string-name><surname>Paul</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Karcher</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Hansen</surname> <given-names>I</given-names></string-name>, <string-name><surname>Baranger</surname> <given-names>DAA</given-names></string-name>, <string-name><surname>Edwards</surname> <given-names>A</given-names></string-name>, <string-name><surname>Grotzinger</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Tucker-Drob</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Kranzler</surname> <given-names>H</given-names></string-name>, <string-name><surname>Davis</surname> <given-names>LK</given-names></string-name>, <string-name><surname>Sanchez-Roige</surname> <given-names>S</given-names></string-name>, <string-name><surname>Polimanti</surname> <given-names>R</given-names></string-name>, <string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name>, <string-name><surname>Edenberg</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Bogdan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Agrawal</surname> <given-names>A</given-names></string-name>, <collab>Substance Use Disorder Working Group of the Psychiatric Genomics Consortium</collab></person-group>. <year>2022a</year>. <article-title>Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders</article-title>. <source>bioRxiv</source>. doi:<pub-id pub-id-type="doi">10.1101/2022.01.06.22268753</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hatoum</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Colbert</surname> <given-names>SMC</given-names></string-name>, <string-name><surname>Polimanti</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>H</given-names></string-name>, <string-name><surname>Walters</surname> <given-names>RK</given-names></string-name>, <string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name>, <string-name><surname>Edenberg</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Bogdan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Agrawal</surname> <given-names>A</given-names></string-name></person-group>. <year>2022b</year>. <article-title>The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates</article-title>. <source>Neuropsychopharmacology</source> <volume>47</volume>:<fpage>1739</fpage>–<lpage>1745</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Tao</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cao</surname> <given-names>X</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>L</given-names></string-name></person-group>. <year>2020</year>. <article-title>The solute carrier transporters and the brain: Physiological and pharmacological implications</article-title>. <source>Asian J Pharm Sci</source> <volume>15</volume>:<fpage>131</fpage>–<lpage>144</lpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hurkmans</surname> <given-names>EGE</given-names></string-name>, <string-name><surname>Koenderink</surname> <given-names>JB</given-names></string-name>, <string-name><surname>van den Heuvel</surname> <given-names>JJMW</given-names></string-name>, <string-name><surname>Versleijen-Jonkers</surname> <given-names>YMH</given-names></string-name>, <string-name><surname>Hillebrandt-Roeffen</surname> <given-names>MHS</given-names></string-name>, <string-name><surname>Groothuismink</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Vos</surname> <given-names>HI</given-names></string-name>, <string-name><surname>van der Graaf</surname> <given-names>WTA</given-names></string-name>, <string-name><surname>Flucke</surname> <given-names>U</given-names></string-name>, <string-name><surname>Muradjan</surname> <given-names>G</given-names></string-name>, <string-name><surname>Schreuder</surname> <given-names>HWB</given-names></string-name>, <string-name><surname>Hagleitner</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Brunner</surname> <given-names>HG</given-names></string-name>, <string-name><surname>Gelderblom</surname> <given-names>H</given-names></string-name>, <string-name><surname>Cleton-Jansen</surname> <given-names>A-M</given-names></string-name>, <string-name><surname>Guchelaar</surname> <given-names>H-J</given-names></string-name>, <string-name><surname>de Bont</surname> <given-names>ESJM</given-names></string-name>, <string-name><surname>Touw</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Nijhoff</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Kremer</surname> <given-names>LCM</given-names></string-name>, <string-name><surname>Caron</surname> <given-names>H</given-names></string-name>, <string-name><surname>Windsor</surname> <given-names>R</given-names></string-name>, <string-name><surname>Patiño-García</surname> <given-names>A</given-names></string-name>, <string-name><surname>González-Neira</surname> <given-names>A</given-names></string-name>, <string-name><surname>Saletta</surname> <given-names>F</given-names></string-name>, <string-name><surname>McCowage</surname> <given-names>G</given-names></string-name>, <string-name><surname>Nagabushan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Catchpoole</surname> <given-names>D</given-names></string-name>, <string-name><surname>Te Loo</surname> <given-names>DMWM</given-names></string-name>, <string-name><surname>Coenen</surname> <given-names>MJH</given-names></string-name></person-group>. <year>2022</year>. <article-title>SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin</article-title>. <source>Front Pharmacol</source> <volume>13</volume>:<fpage>1042989</fpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karlsson</surname> <given-names>R-M</given-names></string-name>, <string-name><surname>Hefner</surname> <given-names>KR</given-names></string-name>, <string-name><surname>Sibley</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Holmes</surname> <given-names>A</given-names></string-name></person-group>. <year>2008</year>. <article-title>Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization</article-title>. <source>Psychopharmacology</source> <volume>200</volume>:<fpage>117</fpage>–<lpage>127</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Yee</surname> <given-names>SW</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>RB</given-names></string-name>, <string-name><surname>Giacomini</surname> <given-names>KM</given-names></string-name></person-group>. <year>2015</year>. <article-title>SLC transporters as therapeutic targets: emerging opportunities</article-title>. <source>Nat Rev Drug Discov</source> <volume>14</volume>:<fpage>543</fpage>–<lpage>560</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname> <given-names>C-J</given-names></string-name>, <string-name><surname>Dib-Hajj</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Renganathan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cummins</surname> <given-names>TR</given-names></string-name>, <string-name><surname>Waxman</surname> <given-names>SG</given-names></string-name></person-group>. <year>2003</year>. <article-title>Modulation of the cardiac sodium channel Nav1.5 by fibroblast growth factor homologous factor 1B</article-title>. <source>J Biol Chem</source> <volume>278</volume>:<fpage>1029</fpage>–<lpage>1036</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mackay</surname> <given-names>TFC</given-names></string-name></person-group>. <year>2014</year>. <article-title>Epistasis and quantitative traits: using model organisms to study gene-gene interactions</article-title>. <source>Nat Rev Genet</source> <volume>15</volume>:<fpage>22</fpage>–<lpage>33</lpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mague</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Isiegas</surname> <given-names>C</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>P</given-names></string-name>, <string-name><surname>Liu-Chen</surname> <given-names>L-Y</given-names></string-name>, <string-name><surname>Lerman</surname> <given-names>C</given-names></string-name>, <string-name><surname>Blendy</surname> <given-names>JA</given-names></string-name></person-group>. <year>2009</year>. <article-title>Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>106</volume>:<fpage>10847</fpage>–<lpage>10852</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCreary</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Keiko McCreary</surname> <given-names>J</given-names></string-name>, <string-name><surname>Sorina Truica</surname> <given-names>L</given-names></string-name>, <string-name><surname>Friesen</surname> <given-names>B</given-names></string-name>, <string-name><surname>Yao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Olson</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Kovalchuk</surname> <given-names>I</given-names></string-name>, <string-name><surname>Cross</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Metz</surname> <given-names>GAS</given-names></string-name></person-group>. <year>2016</year>. <article-title>Altered brain morphology and functional connectivity reflect a vulnerable affective state after cumulative multigenerational stress in rats</article-title>. <source>Neuroscience</source>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.05.046</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McGinnis</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Murrow</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Gartner</surname> <given-names>ZJ</given-names></string-name></person-group>. <year>2019</year>. <article-title>DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors</article-title>. <source>Cell Syst</source> <volume>8</volume>:<fpage>329</fpage>–<lpage>337.</lpage> </mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mohammadnejad</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nygaard</surname> <given-names>M</given-names></string-name>, <string-name><surname>Li</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Li</surname> <given-names>W</given-names></string-name>, <string-name><surname>Lund</surname> <given-names>J</given-names></string-name>, <string-name><surname>Christiansen</surname> <given-names>L</given-names></string-name>, <string-name><surname>Baumbach</surname> <given-names>J</given-names></string-name>, <string-name><surname>Christensen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hjelmborg</surname> <given-names>JVB</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>Q</given-names></string-name></person-group>. <year>2020</year>. <article-title>Generalized correlation coefficient for genome-wide association analysis of cognitive ability in twins</article-title>. <source>Aging (Albany NY)</source> <volume>12</volume>:<fpage>22457</fpage>–<lpage>22494</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mori</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ito</surname> <given-names>S</given-names></string-name>, <string-name><surname>Narita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sawaguchi</surname> <given-names>T</given-names></string-name></person-group>. <year>2004</year>. <article-title>Combined effects of psychostimulants and morphine on locomotor activity in mice</article-title>. <source>J Pharmacol Sci</source> <volume>96</volume>:<fpage>450</fpage>–<lpage>458</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Mulligan</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Mozhui</surname> <given-names>K</given-names></string-name>, <string-name><surname>Prins</surname> <given-names>P</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>RW</given-names></string-name></person-group>. <year>2017</year>. <chapter-title>GeneNetwork: A Toolbox for Systems Genetics</chapter-title> In: <person-group person-group-type="editor"><string-name><surname>Schughart</surname> <given-names>K</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>RW</given-names></string-name></person-group>, editors. <source>Systems Genetics: Methods and Protocols</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer New York</publisher-name>. pp. <fpage>75</fpage>–<lpage>120</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Murphy</surname> <given-names>NP</given-names></string-name>, <string-name><surname>Lam</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Maidment</surname> <given-names>NT</given-names></string-name></person-group>. <year>2001</year>. <article-title>A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice</article-title>. <source>J Neurochem</source> <volume>79</volume>:<fpage>626</fpage>–<lpage>635</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nelson</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Agrawal</surname> <given-names>A</given-names></string-name>, <string-name><surname>Heath</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Bogdan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sherva</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Al-Hasani</surname> <given-names>R</given-names></string-name>, <string-name><surname>Bruchas</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Chou</surname> <given-names>Y-L</given-names></string-name>, <string-name><surname>Demers</surname> <given-names>CH</given-names></string-name>, <string-name><surname>Carey</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Conley</surname> <given-names>ED</given-names></string-name>, <string-name><surname>Fakira</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Farrer</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Goate</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gordon</surname> <given-names>S</given-names></string-name>, <string-name><surname>Henders</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Hesselbrock</surname> <given-names>V</given-names></string-name>, <string-name><surname>Kapoor</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lynskey</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Madden</surname> <given-names>PAF</given-names></string-name>, <string-name><surname>Moron</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Rice</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Saccone</surname> <given-names>NL</given-names></string-name>, <string-name><surname>Schwab</surname> <given-names>SG</given-names></string-name>, <string-name><surname>Shand</surname> <given-names>FL</given-names></string-name>, <string-name><surname>Todorov</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Wallace</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Wray</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>X</given-names></string-name>, <string-name><surname>Degenhardt</surname> <given-names>L</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Hariri</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Kranzler</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bierut</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Clark</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Montgomery</surname> <given-names>GW</given-names></string-name></person-group>. <year>2016</year>. <article-title>Evidence of CNIH3 involvement in opioid dependence</article-title>. <source>Mol Psychiatry</source> <volume>21</volume>:<fpage>608</fpage>–<lpage>614</lpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Leary</surname> <given-names>NA</given-names></string-name>, <string-name><surname>Wright</surname> <given-names>MW</given-names></string-name>, <string-name><surname>Rodney Brister</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ciufo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Haddad</surname> <given-names>D</given-names></string-name>, <string-name><surname>McVeigh</surname> <given-names>R</given-names></string-name>, <string-name><surname>Rajput</surname> <given-names>B</given-names></string-name>, <string-name><surname>Robbertse</surname> <given-names>B</given-names></string-name>, <string-name><surname>Smith-White</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ako-Adjei</surname> <given-names>D</given-names></string-name>, <string-name><surname>Astashyn</surname> <given-names>A</given-names></string-name>, <string-name><surname>Badretdin</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Blinkova</surname> <given-names>O</given-names></string-name>, <string-name><surname>Brover</surname> <given-names>V</given-names></string-name>, <string-name><surname>Chetvernin</surname> <given-names>V</given-names></string-name>, <string-name><surname>Choi</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cox</surname> <given-names>E</given-names></string-name>, <string-name><surname>Ermolaeva</surname> <given-names>O</given-names></string-name>, <string-name><surname>Farrell</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Goldfarb</surname> <given-names>T</given-names></string-name>, <string-name><surname>Gupta</surname> <given-names>T</given-names></string-name>, <string-name><surname>Haft</surname> <given-names>D</given-names></string-name>, <string-name><surname>Hatcher</surname> <given-names>E</given-names></string-name>, <string-name><surname>Hlavina</surname> <given-names>W</given-names></string-name>, <string-name><surname>Joardar</surname> <given-names>VS</given-names></string-name>, <string-name><surname>Kodali</surname> <given-names>VK</given-names></string-name>, <string-name><surname>Li</surname> <given-names>W</given-names></string-name>, <string-name><surname>Maglott</surname> <given-names>D</given-names></string-name>, <string-name><surname>Masterson</surname> <given-names>P</given-names></string-name>, <string-name><surname>McGarvey</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Murphy</surname> <given-names>MR</given-names></string-name>, <string-name><surname>O’Neill</surname> <given-names>K</given-names></string-name>, <string-name><surname>Pujar</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rangwala</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Rausch</surname> <given-names>D</given-names></string-name>, <string-name><surname>Riddick</surname> <given-names>LD</given-names></string-name>, <string-name><surname>Schoch</surname> <given-names>C</given-names></string-name>, <string-name><surname>Shkeda</surname> <given-names>A</given-names></string-name>, <string-name><surname>Storz</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>H</given-names></string-name>, <string-name><surname>Thibaud-Nissen</surname> <given-names>F</given-names></string-name>, <string-name><surname>Tolstoy</surname> <given-names>I</given-names></string-name>, <string-name><surname>Tully</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Vatsan</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Wallin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Webb</surname> <given-names>D</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Landrum</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Kimchi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tatusova</surname> <given-names>T</given-names></string-name>, <string-name><surname>DiCuccio</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kitts</surname> <given-names>P</given-names></string-name>, <string-name><surname>Murphy</surname> <given-names>TD</given-names></string-name>, <string-name><surname>Pruitt</surname> <given-names>KD</given-names></string-name></person-group>. <year>2016</year>. <article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>. <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1189</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Philip</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Duvvuru</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gomero</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ansah</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Blaha</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Cook</surname> <given-names>MN</given-names></string-name>, <string-name><surname>Hamre</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Lariviere</surname> <given-names>WR</given-names></string-name>, <string-name><surname>Matthews</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Mittleman</surname> <given-names>G</given-names></string-name>, <string-name><surname>Goldowitz</surname> <given-names>D</given-names></string-name>, <string-name><surname>Chesler</surname> <given-names>EJ</given-names></string-name></person-group>. <year>2010</year>. <article-title>High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains</article-title>. <source>Genes Brain Behav</source> <volume>9</volume>:<fpage>129</fpage>–<lpage>159</lpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Popova</surname> <given-names>D</given-names></string-name>, <string-name><surname>Desai</surname> <given-names>N</given-names></string-name>, <string-name><surname>Blendy</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Pang</surname> <given-names>ZP</given-names></string-name></person-group>. <year>2019</year>. <article-title>Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry</article-title>. <source>J Neurosci</source> <volume>39</volume>:<fpage>5685</fpage>–<lpage>5696</lpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sanchez-Roige</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fontanillas</surname> <given-names>P</given-names></string-name>, <string-name><surname>Jennings</surname> <given-names>MV</given-names></string-name>, <string-name><surname>Bianchi</surname> <given-names>SB</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hatoum</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Sealock</surname> <given-names>J</given-names></string-name>, <string-name><surname>Davis</surname> <given-names>LK</given-names></string-name>, <string-name><surname>Elson</surname> <given-names>SL</given-names></string-name>, <collab>23andMe Research Team</collab>, <string-name><surname>Palmer</surname> <given-names>AA.</given-names></string-name></person-group> <year>2021</year>. <article-title>Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry</article-title>. <source>Mol Psychiatry</source> <volume>26</volume>:<fpage>6209</fpage>–<lpage>6217</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Savell</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Tuscher</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Zipperly</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Duke</surname> <given-names>CG</given-names></string-name>, <string-name><surname>Phillips</surname> <given-names>RA</given-names> <suffix>3rd</suffix></string-name>, <string-name><surname>Bauman</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Thukral</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sultan</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Goska</surname> <given-names>NA</given-names></string-name>, <string-name><surname>Ianov</surname> <given-names>L</given-names></string-name>, <string-name><surname>Day</surname> <given-names>JJ.</given-names></string-name></person-group> <year>2020</year>. <article-title>A dopamine-induced gene expression signature regulates neuronal function and cocaine response</article-title>. <source>Sci Adv</source> <volume>6</volume>:<fpage>eaba4221</fpage>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schoorlemmer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Goldfarb</surname> <given-names>M</given-names></string-name></person-group>. <year>2001</year>. <article-title>Fibroblast growth factor homologous factors are intracellular signaling proteins</article-title>. <source>Curr Biol</source> <volume>11</volume>:<fpage>793</fpage>–<lpage>797</lpage>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seiffert</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pendziwiat</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bierhals</surname> <given-names>T</given-names></string-name>, <string-name><surname>Goel</surname> <given-names>H</given-names></string-name>, <string-name><surname>Schwarz</surname> <given-names>N</given-names></string-name>, <string-name><surname>van der Ven</surname> <given-names>A</given-names></string-name>, <string-name><surname>Boßelmann</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Lemke</surname> <given-names>J</given-names></string-name>, <string-name><surname>Syrbe</surname> <given-names>S</given-names></string-name>, <string-name><surname>Willemsen</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Hedrich</surname> <given-names>UBS</given-names></string-name>, <string-name><surname>Helbig</surname> <given-names>I</given-names></string-name>, <string-name><surname>Weber</surname> <given-names>Y.</given-names></string-name></person-group> <year>2022</year>. <article-title>Modulating effects of FGF12 variants on NaV1.2 and NaV1.6 being associated with developmental and epileptic encephalopathy and Autism spectrum disorder: A case series</article-title>. <source>EBioMedicine</source> <volume>83</volume>:<fpage>104234</fpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Severino</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Mittal</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hakimian</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Velarde</surname> <given-names>N</given-names></string-name>, <string-name><surname>Minasyan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Albert</surname> <given-names>R</given-names></string-name>, <string-name><surname>Torres</surname> <given-names>C</given-names></string-name>, <string-name><surname>Romaneschi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Johnston</surname> <given-names>C</given-names></string-name>, <string-name><surname>Tiwari</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Taylor</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Gavériaux-Ruff</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kieffer</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Evans</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Cahill</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Walwyn</surname> <given-names>WM</given-names></string-name></person-group>. <year>2020</year>. <article-title>μ-Opioid Receptors on Distinct Neuronal Populations Mediate Different Aspects of Opioid Reward-Related Behaviors</article-title>. <source>eNeuro</source> <volume>7</volume>. doi:<pub-id pub-id-type="doi">10.1523/ENEURO.0146-20.2020</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sloan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Arends</surname> <given-names>D</given-names></string-name>, <string-name><given-names>W.</given-names> <surname>Broman K</surname></string-name>, <string-name><surname>Centeno</surname> <given-names>A</given-names></string-name>, <string-name><surname>Furlotte</surname> <given-names>N</given-names></string-name>, <string-name><surname>Nijveen</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yan</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>X</given-names></string-name>, <string-name><given-names>W.</given-names> <surname>Williams R</surname></string-name>, <string-name><surname>Prins</surname> <given-names>P</given-names></string-name></person-group>. <year>2016</year>. <article-title>GeneNetwork: framework for web-based genetics</article-title>. <source>J Open Source Softw</source> <volume>1</volume>:<fpage>25</fpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Greene-Naples</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Lyle</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Iordanou</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Felder</surname> <given-names>JN</given-names></string-name></person-group>. <year>2009</year>. <article-title>The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors</article-title>. <source>J Pharmacol Exp Ther</source> <volume>330</volume>:<fpage>468</fpage>–<lpage>475</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sochacka</surname> <given-names>M</given-names></string-name>, <string-name><surname>Opalinski</surname> <given-names>L</given-names></string-name>, <string-name><surname>Szymczyk</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zimoch</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Czyrek</surname> <given-names>A</given-names></string-name>, <string-name><surname>Krowarsch</surname> <given-names>D</given-names></string-name>, <string-name><surname>Otlewski</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zakrzewska</surname> <given-names>M</given-names></string-name></person-group>. <year>2020</year>. <article-title>FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner</article-title>. <source>Cell Commun Signal</source> <volume>18</volume>:<fpage>69</fpage>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stuart</surname> <given-names>T</given-names></string-name>, <string-name><surname>Butler</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hoffman</surname> <given-names>P</given-names></string-name>, <string-name><surname>Hafemeister</surname> <given-names>C</given-names></string-name>, <string-name><surname>Papalexi</surname> <given-names>E</given-names></string-name>, <string-name><surname>Mauck</surname> <given-names>WM</given-names> <suffix>3rd</suffix></string-name>, <string-name><surname>Hao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Stoeckius</surname> <given-names>M</given-names></string-name>, <string-name><surname>Smibert</surname> <given-names>P</given-names></string-name>, <string-name><surname>Satija</surname> <given-names>R.</given-names></string-name></person-group> <year>2019</year>. <article-title>Comprehensive Integration of Single-Cell Data</article-title>. <source>Cell</source> <volume>177</volume>:<fpage>1888</fpage>–<lpage>1902.</lpage> </mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Theriot</surname> <given-names>J</given-names></string-name>, <string-name><surname>Sabir</surname> <given-names>S</given-names></string-name>, <string-name><surname>Azadfard</surname> <given-names>M.</given-names></string-name></person-group> <year>2022</year>. <source>Opioid AntagonistsStatPearls</source>. <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing.</publisher-name></mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Torrents</surname> <given-names>D</given-names></string-name>, <string-name><surname>Estévez</surname> <given-names>R</given-names></string-name>, <string-name><surname>Pineda</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fernández</surname> <given-names>E</given-names></string-name>, <string-name><surname>Lloberas</surname> <given-names>J</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>YB</given-names></string-name>, <string-name><surname>Zorzano</surname> <given-names>A</given-names></string-name>, <string-name><surname>Palacín</surname> <given-names>M.</given-names></string-name></person-group> 1. <year>1998</year>. <article-title>Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance</article-title>. <source>J Biol Chem</source> <volume>273</volume>:<fpage>32437</fpage>–<lpage>32445</lpage>.</mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Torrents</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mykkänen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pineda</surname> <given-names>M</given-names></string-name>, <string-name><surname>Feliubadaló</surname> <given-names>L</given-names></string-name>, <string-name><surname>Estévez</surname> <given-names>R</given-names></string-name>, <string-name><surname>de Cid</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sanjurjo</surname> <given-names>P</given-names></string-name>, <string-name><surname>Zorzano</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nunes</surname> <given-names>V</given-names></string-name>, <string-name><surname>Huoponen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Reinikainen</surname> <given-names>A</given-names></string-name>, <string-name><surname>Simell</surname> <given-names>O</given-names></string-name>, <string-name><surname>Savontaus</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Aula</surname> <given-names>P</given-names></string-name>, <string-name><surname>Palacín</surname> <given-names>M.</given-names></string-name></person-group> <year>1999</year>. <article-title>Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene</article-title>. <source>Nat Genet</source> <volume>21</volume>:<fpage>293</fpage>–<lpage>296</lpage>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uffelmann</surname> <given-names>E</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>QQ</given-names></string-name>, <string-name><surname>Munung</surname> <given-names>NS</given-names></string-name>, <string-name><surname>de Vries</surname> <given-names>J</given-names></string-name>, <string-name><surname>Okada</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>HC</given-names></string-name>, <string-name><surname>Lappalainen</surname> <given-names>T.</given-names></string-name></person-group> <year>2021</year>. <article-title>Genome-wide association studies</article-title>. <source>Nature Reviews Methods Primers</source> <volume>1</volume>:<fpage>1</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>YP</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>SG</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>YS</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>B</given-names></string-name>, <string-name><surname>Xun</surname> <given-names>X</given-names></string-name>, <string-name><surname>Lai</surname> <given-names>JH</given-names></string-name></person-group>. <year>2015</year>. <article-title>Dopamine receptor D1 but not D3 essential for morphine-induced conditioned responses</article-title>. <source>Genet Mol Res</source> <volume>14</volume>:<fpage>180</fpage>–<lpage>189</lpage>.</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Watson</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Ashbrook</surname> <given-names>DG</given-names></string-name></person-group>. <year>2020</year>. <article-title>GeneNetwork: a continuously updated tool for systems genetics analyses</article-title>. <source>bioRxiv</source>. doi:<pub-id pub-id-type="doi">10.1101/2020.12.23.424047</pub-id></mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname> <given-names>W-H</given-names></string-name>, <string-name><surname>Hemani</surname> <given-names>G</given-names></string-name>, <string-name><surname>Haley</surname> <given-names>CS</given-names></string-name></person-group>. <year>2014</year>. <article-title>Detecting epistasis in human complex traits</article-title>. <source>Nat Rev Genet</source> <volume>15</volume>:<fpage>722</fpage>–<lpage>733</lpage>.</mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wildburger</surname> <given-names>NC</given-names></string-name>, <string-name><surname>Ali</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Hsu</surname> <given-names>W-CJ</given-names></string-name>, <string-name><surname>Shavkunov</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Nenov</surname> <given-names>MN</given-names></string-name>, <string-name><surname>Lichti</surname> <given-names>CF</given-names></string-name>, <string-name><surname>LeDuc</surname> <given-names>RD</given-names></string-name>, <string-name><surname>Mostovenko</surname> <given-names>E</given-names></string-name>, <string-name><surname>Panova-Elektronova</surname> <given-names>NI</given-names></string-name>, <string-name><surname>Emmett</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Nilsson</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Laezza</surname> <given-names>F</given-names></string-name></person-group>. <year>2015</year>. <article-title>Quantitative proteomics reveals protein-protein interactions with fibroblast growth factor 12 as a component of the voltage-gated sodium channel 1.2 (nav1.2) macromolecular complex in Mammalian brain</article-title>. <source>Mol Cell Proteomics</source> <volume>14</volume>:<fpage>1288</fpage>–<lpage>1300</lpage>.</mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Williams</surname> <given-names>RW</given-names></string-name>, <string-name><surname>Gu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Qi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>L</given-names></string-name></person-group>. <year>2001</year>. <article-title>The genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis</article-title>. <source>Genome Biol</source> <volume>2</volume>:<fpage>RESEARCH0046</fpage>.</mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hu</surname> <given-names>XT</given-names></string-name>, <string-name><surname>Cooper</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Moratalla</surname> <given-names>R</given-names></string-name>, <string-name><surname>Graybiel</surname> <given-names>AM</given-names></string-name>, <string-name><surname>White</surname> <given-names>FJ</given-names></string-name>, <string-name><surname>Tonegawa</surname> <given-names>S</given-names></string-name></person-group>. <year>1994</year>. <article-title>Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice</article-title>. <source>Cell</source> <volume>79</volume>:<fpage>945</fpage>–<lpage>955</lpage>.</mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yam</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Loh</surname> <given-names>YC</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Khadijah Adam</surname> <given-names>S</given-names></string-name>, <string-name><surname>Abdul Manan</surname> <given-names>N</given-names></string-name>, <string-name><surname>Basir</surname> <given-names>R</given-names></string-name></person-group>. <year>2018</year>. <article-title>General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation</article-title>. <source>Int J Mol Sci</source> <volume>19</volume>. doi:<pub-id pub-id-type="doi">10.3390/ijms19082164</pub-id></mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kirov</surname> <given-names>S</given-names></string-name>, <string-name><surname>Snoddy</surname> <given-names>J</given-names></string-name></person-group>. <year>2005</year>. <article-title>WebGestalt: an integrated system for exploring gene sets in various biological contexts</article-title>. <source>Nucleic Acids Res</source> <volume>33</volume>:<fpage>W741</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>J-T</given-names></string-name>, <string-name><surname>Hang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>T</given-names></string-name></person-group>. <year>2020</year>. <article-title>Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective</article-title>. <source>Front Pharmacol</source> <volume>11</volume>:<fpage>1078</fpage>.</mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname> <given-names>H</given-names></string-name>, <string-name><surname>Rentsch</surname> <given-names>CT</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Kember</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Nunez</surname> <given-names>YZ</given-names></string-name>, <string-name><surname>Sherva</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Tate</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Dao</surname> <given-names>C</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>K</given-names></string-name>, <string-name><surname>Polimanti</surname> <given-names>R</given-names></string-name>, <string-name><surname>Farrer</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Justice</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Kranzler</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Gelernter</surname> <given-names>J</given-names></string-name>, <collab>Veterans Affairs Million Veteran Program</collab></person-group>. <year>2020</year>. <article-title>Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study</article-title>. <source>JAMA Psychiatry</source> <volume>77</volume>:<fpage>1072</fpage>–<lpage>1080</lpage>.</mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ziebarth</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Cui</surname> <given-names>Y</given-names></string-name></person-group>. <year>2017</year>. <article-title>Precise Network Modeling of Systems Genetics Data Using the Bayesian Network Webserver</article-title>. <source>Methods Mol Biol</source> <volume>1488</volume>:<fpage>319</fpage>–<lpage>335</lpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.108845.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Flint</surname>
<given-names>Jonathan</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution>
</institution-wrap>
<city>Los Angeles</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Compelling</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Fundamental</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study integrates large-scale behavioral, genetic, and molecular analyses in animal models to investigate morphine response. Utilizing high-quality, time-series Quantitative Trait Loci (QTL) mapping, the work provides <bold>compelling</bold> evidential support for novel, time-dependent genetic interactions (epistasis). A <bold>fundamental</bold> result of this rigorous analysis is the discovery of a novel Oprm1-Fgf12-MAPK signaling pathway, which offers new insights into the mechanisms of opioid sensitivity.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.108845.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The study by Lemen et al. represents a comprehensive and unique analysis of gene networks in rat models of opioid use disorder, using multiple strains and both sexes. It provides a time-series analysis of Quantitative Trait Loci (QTLs) in response to morphine exposure.</p>
<p>Strengths:</p>
<p>A key finding is the identification of a previously unknown morphine-sensitive pathway involving Oprm1 and Fgf12, which activates a cascade through MAPK kinases in D1 medium spiny neurons (MSNs). Strengths include the large-scale, multi-strain, sex-inclusive design, the time-series QTL mapping provides dynamic insights, and the discovery of an Oprm1-Fgf12-MAPK signaling pathway in D1 MSNs, which is novel and relevant.</p>
<p>Weaknesses:</p>
<p>(1) The proposed involvement of Nav1.2 (SCN2A) as a downstream target of the Oprm1-Fgf12 pathway requires further analysis/evidence. Is Nav1.2 (SCN2A) expressed in D1 neurons?</p>
<p>The authors mentioned that SCN8A (Nav1.6) was tested as a candidate mediator of Oprm1-Fgf12 loci and variation in locomotor activity. However, the proposed model supports SCN2A as a target rather than SCN8A. This is somewhat unexpected since SCN8A is highly abundant in MSN.</p>
<p>Can the authors provide expression data for SCN2A, Oprm1, and Fgf12 in D1 vs. D2 MSNs?</p>
<p>(2) The authors should consider adding a reference to FGF12 in Schizophrenia (PMC8027596) in the Introduction.</p>
<p>(3) There is recent evidence supporting the druggability of other intracellular FGFs, such as FGF14 (PMC11696184) and FGF13 (PMC12259270), through their interactions with Nav channels. What are the implications of these findings for drug discovery in the context of the present study? Could FGF12 be considered a potential druggable therapeutic target for opioid use disorder (OUD)?</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.108845.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This highly novel and significant manuscript re-analyzes behavioral QTL data derived from morphine locomotor activity in the BXD recombinant inbred panel. The combination of interacting behavioral-pharmacology (morphine and naltrexone) time course data, high-resolution mouse genetic analyses, genetic analysis of gene expression (eQTLs), cross-species analysis with human gene expression and genetic data, and molecular modeling approaches with Bayesian network analysis produces new information on loci modulating morphine locomotor activity.</p>
<p>Furthermore, the identification of time-wise epistatic interactions between the Oprm1 and Fgf12 loci is highly novel and points to methodological approaches for identifying other epistatic interactions using animal model genetic studies.</p>
<p>Strengths:</p>
<p>(1) Use of state-of-the art genetic tools for mapping behavioral phenotypes in mouse models.</p>
<p>(2) Adequately powered analysis incorporating both sexes and time course analyses.</p>
<p>(3) Detection of time and sex-dependent interactions of two QTL loci modulating morphine locomotor activity.</p>
<p>(4) Identification of putative candidate genes by combined expression and behavioral genetic analyses.</p>
<p>(5) Use of Bayesian analysis to model causal interactions between multiple genes and behavioral time points.</p>
<p>Weaknesses:</p>
<p>(1) There is a need for careful editing of the text and figures to eliminate multiple typographical and other compositional errors.</p>
<p>(2) There are multiple examples of overstating the possible significance of results that should be corrected or at least directly pointed out as weaknesses in the Discussion. These include:</p>
<p>a) Assumption that the Oprm1 gene is the causal candidate gene for the major morphine locomotor Chr10 QTL at the early time epochs. Oprm1 is 400,000 bp away from the support interval of the Mor10a QTL locus, and there is no mention as to whether the Oprm1 mRNA eQTL overlaps with Mor10a.</p>
<p>b) Although the Bayesian analysis of possible complex interactions between Oprm1, Fgf12, other interacting genes, and behaviors is very innovative and produces testable hypotheses, a more straightforward mediation analysis of causal relationships between genotype, gene expression, and phenotype would have added strength to the arguments for the causal role of these individual genes.</p>
<p>c) The GWAS data analysis for Oprm1 and Fgf12 is incomplete in not mentioning actual significance levels for Oprm1 and perhaps overstating the nominal significance findings for Fgf12.</p>
<p>Appraisal:</p>
<p>The authors largely succeeded in reaching goals with novel findings and methodology.</p>
<p>Significance of Findings:</p>
<p>This study will likely spur future direct experimental studies to test hypotheses generated by this complex analysis. Additionally, the broad methodological approach incorporating time course genetic analyses may encourage other studies to identify epistatic interactions in mouse genetic studies.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.108845.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This is a clearly written paper that describes the reanalysis of data from a BXD study of the locomotor response to morphine and naloxone. The authors detect significant loci and an epistatic interaction between two of those loci. Single-cell data from outbred rats is used to investigate the interaction. The authors also use network methods and incorporate human data into their analysis.</p>
<p>Strengths:</p>
<p>One major strength of this work is the use of granular time-series data, enabling the identification of time-point-specific QTL. This allowed for the identification of an additional, distinct QTL (the Fgf12 locus) in this work compared to previously published analysis of these data, as well as the identification of an epistatic effect between Oprm1 (driving early stages of locomotor activation) and Fgf12 (driving later stages).</p>
<p>Weaknesses:</p>
<p>(1) What criteria were used to determine whether the epistatic interaction was significant? How many possible interactions were explored?</p>
<p>(2) Results are presented for males and females separately, but the decision to examine the two sexes separately was never explained or justified. Since it is not standard to perform GWAS broken down by sex, some initial explanation of this decision is needed. Perhaps the discussion could also discuss what (if anything) was learned as a result of the sex-specific analysis. In the end, was it useful?</p>
<p>(3) The confidence intervals for the results were not well described, although I do see them in one of the tables. The authors used a 1.5 support interval, but didn't offer any justification for this decision. Is that a 95% confidence interval? If not, should more consideration have been given to genes outside that interval? For some of the QTLs that are not the focus of this paper, the confidence intervals were very large (&gt;10 Mb). Is that typical for BXDs?</p>
</body>
</sub-article>
</article>